Malignant neoplasm of kidney, except renal pelvis

C3_KIDNEY_NOTRENALPELVIS

kidney neoplasm: A benign or malignant neoplasm affecting the kidney. Representative examples of benign renal neoplasms include fibroma, lipoma, oncocytoma, and juxtaglomerular cell tumor. Representative examples of malignant renal neoplasms include renal cell carcinoma, renal pelvis carcinoma, Wilms tumor, rhabdoid tumor, sarcoma, and lymphoma.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Cause of death: ICD-10 — C64 Cause of death: ICD-9 — 1890 Cause of death: ICD-8 — 1890 Cancer registry: Topography ICD-O-3 — C64 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 2 out of 7 registries used, show all original rules.	3674
4. Check minimum number of events None	3674
5. Include endpoints C3_KIDNEY_CLEAR_CELL_CARCINOMA C3_KIDNEY_PAPILLARYADENO	3674
6. Filter based on genotype QC (FinnGen only)	3550

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF9

NAME	C3_KIDNEY_NOTRENALPELVIS
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	C3_KIDNEY_CLEAR_CELL_CARCINOMA\|C3_KIDNEY_PAPILLARYADENO
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C64
COD_ICD_9	1890
COD_ICD_8	1890
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C64
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of kidney, except renal pelvis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3550	1286	2264
Unadjusted period prevalence (%)	0.83	0.46	1.04
Median age at first event (years)	66.94	66.19	67.36

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3673: Matched controls
36730

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

321.7

304

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

319.5

302

L01XE04

ATC

[U] sunitinib

+∞

315.2

298

C61

ICD-10 Finland

Malignant neoplasm of prostate

638.0

307.7

348

XX3DW

NOMESCO Finland

Time consuming IT work

7.5

307.7

513

775

TPH07

NOMESCO Finland

Cathetrisation of artery

5.9

307.7

985

2152

WF002

NOMESCO Finland

Radical radiotherapy

81.0

307.7

192

KAC00

NOMESCO Finland

Nephrectomy

244.2

307.7

229

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

307.7

3326

A03FA01

ATC

metoclopramide; systemic, rectal

6.1

307.7

974

2051

197

Kela drug reimbursment

Sunitinib

+∞

307.7

437

H02AB02

ATC

dexamethasone; systemic

28.2

307.7

421

168

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

11.1

307.7

669

721

JN4AD

NOMESCO Finland

Body CT examination

16.1

307.7

1136

994

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

6.1

307.7

1082

2363

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

307.7

389

WF049

NOMESCO Finland

Radiotherapy of metastasis

1251.2

307.7

341

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

52.1

307.7

202

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

935.9

307.7

746

KAD01

NOMESCO Finland

Percutaneous endoscopic partial nephrectomy

404.4

307.7

460

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

307.7

1699

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

996

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

416.5

307.7

2382

162

JN4BD

NOMESCO Finland

Extensive body CT

14.1

307.7

914

842

KAC10

NOMESCO Finland

Total nephrectomy with capsule

2114.9

307.7

935

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

307.7

1105

A04AA02

ATC

granisetron; systemic, transdermal

219.3

307.7

207

KAD00

NOMESCO Finland

Partial nephrectomy

369.7

307.7

482

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

307.7

416

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

7113.6

307.7

1054

B01AB10

ATC

tinzaparin; parenteral

10.3

307.7

993

1277

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

159.0

307.7

224

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

307.7

320

Z51.5

ICD-10 Finland

Palliative care

8.6

307.7

511

681

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

36.0

307.7

467

148

JN4CD

NOMESCO Finland

Very extensive body CT

30.8

307.7

542

205

WX302

NOMESCO Finland

Thoracal epidural anesthesy

24.4

307.7

647

319

WX408

NOMESCO Finland

General anesthesy, balanced

3.8

304.9

1356

4940

KA1AE

NOMESCO Finland

Kidney ultrasound examination

11.1

296.1

327

322

1502

Kela drug reimbursment

Cabozantinib

+∞

294.8

279

3012

Kela drug reimbursment

Cabozantinib

+∞

288.4

273

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

9.2

285.3

362

430

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

89.6

262.9

138

WX402

NOMESCO Finland

General anaesthesia

3.8

251.6

991

3276

B01AB05

ATC

enoxaparin; parenteral

3.2

246.9

1568

6958

WZC30

NOMESCO Finland

Teaching

4.0

232.1

787

2335

A04AA01

ATC

ondansetron; systemic, rectal

9.5

230.9

283

320

322

Kela drug reimbursment

Sunitinib

+∞

229.6

218

U75

ICPC

Malignant neoplasm of kidney

778.1

225.6

220

WZC00

NOMESCO Finland

Treatment plan or consultation

3.1

220.3

1392

6082

N02AA05

ATC

oxycodone; systemic

3.5

214.1

924

3209

L01EX07

ATC

cabozantinib; oral

+∞

210.5

200

159

Kela drug reimbursment

Pazopanib

+∞

210.5

200

C64.80

ICD-10 Finland

Wilms tumour

+∞

209.4

199

ZXE20

NOMESCO Finland

More than three and less than five hours

3.6

203.6

807

2645

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

200.9

191

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

9.7

199.6

240

264

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

7.8

199.1

288

398

L02AE02

ATC

leuprorelin; implant, parenteral

54.5

195.3

111

NK6AN

NOMESCO Finland

Total body bone isotope imaging

50.2

193.8

112

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

102.8

193.4

100

8317/3-C64.9

ICD-O-3

Renal cell carcinoma, chromophobe type of kidney, NOS

+∞

192.4

183

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

182.8

174

N02AX02

ATC

tramadol; systemic, rectal

2.6

176.6

1964

11180

ZXC96

NOMESCO Finland

Robot assisted procedure

21.5

174.9

131

JN3AD

NOMESCO Finland

Abdominal CT examination

3.7

173.8

636

1963

116

Kela drug reimbursment

Prostate cancer

+∞

172.2

164

7125

FHL

Nephrectomy (extrrafascial)

1679.3

161.6

156

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

160.2

2094

12661

R31

ICD-10 Finland

Unspecified haematuria

3.3

148.4

663

2309

L01EX01

ATC

sunitinib; oral

+∞

145.8

139

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

221.8

145.1

149

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

8.9

142.5

181

213

D30.0

ICD-10 Finland

Benign neoplasm: Kidney

14.9

142.0

127

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.6

140.1

527

1644

8000/3-C64.9

ICD-O-3

Neoplasm, malignant of kidney, NOS

+∞

139.5

133

L01XE26

ATC

[U] cabozantinib

+∞

137.3

131

L01XE11

ATC

[U] pazopanib

+∞

137.3

131

158

Kela drug reimbursment

Everolimus

+∞

137.3

131

WW500

NOMESCO Finland

Blood transfusion

7.4

136.9

205

293

180

Kela drug reimbursment

Interferon alfa

+∞

135.2

129

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

5.3

131.6

277

555

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

72.4

131.1

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

6.2

129.5

230

393

L02BG04

ATC

letrozole; oral

30.3

125.9

L03AA02

ATC

filgrastim; parenteral

51.7

123.5

115

Kela drug reimbursment

Breast cancer

+∞

122.6

117

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

119.4

114

168

Kela drug reimbursment

Axitinib

+∞

117.3

112

1890B

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,ADENOCARCINOMA]

+∞

116.3

111

UKC02

NOMESCO Finland

Cystoscopy

2.6

115.6

848

3817

WF004

NOMESCO Finland

Palliative radiotherapy

1122.0

112.1

109

ZXE10

NOMESCO Finland

More than one and less than three hours

2.2

111.1

1453

8393

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

27.0

108.0

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

107.8

103

PJA12

NOMESCO Finland

Sentinel node biopsy

364.4

106.8

107

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

8.7

106.7

137

163

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

105.8

959

4736

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.6

103.3

376

1139

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

24.0

102.1

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.1

102.0

472

1658

U14

ICPC

Kidney symptom/complaint

7.0

100.7

156

231

R4110

NOMESCO Finland

Physiotherapy

2.2

97.8

1137

6201

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.5

97.1

725

3265

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

13.3

95.7

KA3LT

NOMESCO Finland

Njurlesion coagulation

171.3

95.7

100

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

5.2

95.1

200

399

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

324.6

93.3

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

93.1

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

3.2

93.0

409

1391

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

111.9

90.4

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

313.6

90.2

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

11.1

88.8

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

16.9

87.6

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.5

87.2

317

957

TK800

NOMESCO Finland

Hemodialysis

5.4

85.0

173

335

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.9

83.8

190

404

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

82.6

JN6AD

NOMESCO Finland

CT of torso and neck

13.0

81.2

GD1AD

NOMESCO Finland

Thorax CT examination

3.5

80.8

292

877

343

Kela drug reimbursment

Pazopanib

+∞

80.5

361

Kela drug reimbursment

Axitinib

+∞

80.5

N18.8

ICD-10 Finland

Other chronic renal failure

4.3

80.0

212

511

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

795.3

79.7

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

79.5

ZX120

NOMESCO Finland

Intravenous

3.1

79.4

369

1292

ZX090

NOMESCO Finland

Other technic of radiotherapy

110.1

79.2

B03XA02

ATC

darbepoetin alfa; parenteral

6.0

79.2

142

244

A06AH03

ATC

naloxegol; oral

14.1

78.5

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

78.4

A79

ICPC

Malignancy NOS

141.5

78.3

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

3.7

78.0

262

749

A11CC03

ATC

alfacalcidol; systemic

4.7

77.6

183

402

D41.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Renal pelvis

107.5

77.2

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

6.5

76.0

126

200

Y77

ICPC

Malignant neoplasm prostate

199.2

75.5

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

75.3

KCD02

NOMESCO Finland

Transurethral resection of bladder

12.8

75.2

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.7

74.5

179

399

L01XE10

ATC

[U] everolimus

+∞

74.2

WF003

NOMESCO Finland

Adjuvant radiotherapy

255.3

73.6

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

732.7

73.4

L01BC06

ATC

capecitabine; oral

+∞

73.2

V03AE01

ATC

polystyrene sulfonate; oral

6.6

72.9

119

186

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

15.1

72.5

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

11.8

72.3

340

Kela drug reimbursment

Everolimus

+∞

72.1

KAC01

NOMESCO Finland

Percutaneous endoscopic nephrectomy

359.1

70.9

HAB40

NOMESCO Finland

Wedge excision of mammary gland

16.6

70.3

D44.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Adrenal gland

8.0

69.9

121

WX704

NOMESCO Finland

Intubation

2.9

69.1

346

1261

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

6.8

68.4

108

163

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

680.7

68.2

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

680.7

68.2

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.4

68.2

515

2304

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

659.9

66.1

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

65.8

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.5

65.1

450

1930

C08CA01

ATC

amlodipine; oral

1.8

64.3

1711

11982

N02BE01

ATC

paracetamol; systemic, rectal

2.3

64.2

3211

27484

1890X

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,EI HIST VAHV]

+∞

63.7

L03AA13

ATC

pegfilgrastim; parenteral

220.5

63.3

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

21.6

63.1

L02BB03

ATC

bicalutamide; oral

+∞

62.7

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

62.7

C648, ,

ICD-10 Finland

+∞

62.7

M04AA01

ATC

allopurinol; systemic

2.1

62.5

700

3678

L01XE17

ATC

[U] axitinib

+∞

61.6

198

Kela drug reimbursment

Sorafenib

+∞

61.6

R93.4

ICD-10 Finland

Abnormal findings on diagnostic imaging of urinary organs

9.0

61.5

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

7.0

61.5

137

M05BX04

ATC

denosumab; parenteral

3.3

61.0

248

800

L01EK01

ATC

axitinib; oral

+∞

60.6

S18

ICPC

Laceration/cut

1.8

60.3

1686

11903

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

24.2

60.2

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

597.7

59.9

A12AA04

ATC

calcium carbonate; oral

5.4

59.0

117

221

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

9.0

58.8

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

302.0

58.4

R50.9

ICD-10 Finland

Fever, unspecified

2.2

58.3

562

2778

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

58.1

1377

9240

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

296.6

57.4

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.5

57.2

112

209

XKD00

NOMESCO Finland

Uroflowmetry

2.0

57.0

717

3919

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.4

56.9

217

672

SPAT1153

SPAT

Removal of sutures

1.8

56.4

1190

7699

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

55.5

669

3598

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.4

54.7

209

648

ZXA05

NOMESCO Finland

Left side

1.8

52.5

981

6095

R4190

NOMESCO Finland

Nutritional therapy

4.5

52.4

129

293

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

52.2

ZX070

NOMESCO Finland

Intensity modified radiotherapy

182.6

52.0

HAC20

NOMESCO Finland

Total mastectomy

94.8

50.9

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

50.7

599

3189

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

6.4

50.4

134

Z31.5

ICD-10 Finland

Genetic counselling

4.2

50.2

137

337

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

50.1

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

494.5

49.5

AA1BD

NOMESCO Finland

Extensive CT of head and brain

4.9

48.9

109

228

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

4.8

48.9

112

240

HA1AA

NOMESCO Finland

X-ray mammography

4.3

48.6

126

298

8960/3-C64.9

ICD-O-3

Nephroblastoma, NOS, of kidney, NOS

+∞

48.0

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.1

47.4

209

706

BCA31

NOMESCO Finland

Endoscopic unilateral adrenalectomy

12.6

47.0

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.9

46.8

232

837

C03CA01

ATC

furosemide; systemic

1.7

46.5

1399

9869

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

7.7

46.3

L01EX03

ATC

pazopanib; oral

+∞

45.9

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.0

45.8

207

709

205

Kela drug reimbursment

Chronic hypertension

1.7

45.8

1303

9050

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.8

45.5

145

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

453.3

45.3

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

45.2

2259

18062

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.1

45.2

194

645

N02AA01

ATC

morphine; systemic, rectal

5.2

45.0

186

L01EG02

ATC

everolimus; oral

+∞

44.9

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.3

44.8

116

274

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.8

44.8

234

868

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.9

44.5

203

C79.7

ICD-10 Finland

Secondary malignant neoplasm of adrenal gland

+∞

43.8

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

43.8

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

432.7

43.3

C50.99

ICD-10 Finland

Breast, unspecified

432.7

43.3

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

42.8

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

42.5

724

4334

J01MA02

ATC

ciprofloxacin; systemic

1.6

42.5

1427

10290

KH1AD

NOMESCO Finland

CT of urinary organs

3.3

42.4

166

522

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.6

42.3

148

N18.0

ICD-10 Finland

End-stage renal disease

5.1

41.9

175

L01XE05

ATC

[U] sorafenib

+∞

41.7

Z85.5

ICD-10 Finland

Personal history of malignant neoplasm of urinary tract

+∞

41.7

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

41.7

N28.1

ICD-10 Finland

Cyst of kidney

4.4

41.7

105

243

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.2

41.6

174

570

WX725

NOMESCO Finland

Noninvasive ventilation

2.8

41.0

218

816

L03AA04, ,

ATC

145.0

40.8

BCA30

NOMESCO Finland

Unilateral adrenalectomy

111.3

40.8

E83.50

ICD-10 Finland

Hypercalcemia

6.3

40.7

112

PHE70

NOMESCO Finland

Thrombectomy of inferior vena cava

+∞

40.7

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

40.7

ZXA00

NOMESCO Finland

Right side

1.7

39.8

1008

6740

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

39.6

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

8.5

39.5

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.6

39.4

246

998

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

39.4

1076

7333

ZZR00

NOMESCO Finland

Flap of skin

7.8

39.1

A02BC02

ATC

pantoprazole; systemic

1.6

39.1

2342

19229

Z94.0

ICD-10 Finland

Kidney transplant status

6.3

38.9

104

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

11.2

38.9

XX2RW, ,

NOMESCO Finland

9.1

38.6

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

38.6

8010/3-C64.9

ICD-O-3

Carcinoma, NOS, of kidney, NOS

+∞

38.6

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

38.6

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

38.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.3

37.9

297

1337

J01MA12

ATC

levofloxacin; systemic

1.8

37.2

681

4150

H05BX01

ATC

cinacalcet; oral

8.0

37.1

A04AA55

ATC

palonosetron, combinations; systemic

+∞

36.5

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

36.5

18900

ICD-8 Finland

Malignant neoplasm of other and unspecified urinary organs, Kidney, except pelvis

+∞

36.5

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

3.1

35.7

154

513

Z90.5

ICD-10 Finland

Acquired absence of kidney

53.1

35.4

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

5.3

35.3

136

Z51.0

ICD-10 Finland

Radiotherapy session

350.6

35.0

JFB30

NOMESCO Finland

Right hemicolectomy

7.8

34.9

KA4AT

NOMESCO Finland

Cytology of kidney with ultrasound guidance

96.0

34.8

D70.82

ICD-10 Finland

Drug-induced neutropenia

11.0

34.7

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

51.8

34.5

1890A

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,NEPHROBLASTOMA]

+∞

34.4

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

76.9

33.9

321

Kela drug reimbursment

Paricalcitol and cinacalcet

7.7

33.5

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

33.4

ZX112

NOMESCO Finland

Subcutaneous

6.5

33.2

127

Kela drug reimbursment

Transplant complication

5.2

33.2

136

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

63.9

33.0

V03AE02

ATC

sevelamer; oral

8.4

33.0

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

330.1

32.9

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

32.7

2429

20490

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

32.5

1107

7890

196

Kela drug reimbursment

Paricalcitol and cinacalcet

9.0

32.5

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

32.3

A04AD12

ATC

aprepitant; systemic

+∞

32.3

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

32.3

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

32.3

L03AB05

ATC

interferon alfa-2b; parenteral

40.5

32.1

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.4

32.0

236

1033

RJ128, ,

NOMESCO Finland

11.9

31.6

ZX050

NOMESCO Finland

Stereotactic radiotherapy

48.0

31.6

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

+∞

31.3

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

31.3

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

31.3

B01AB04

ATC

dalteparin; parenteral

2.6

31.1

189

756

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

161.4

30.7

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

161.4

30.7

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

30.2

348

1819

137

Kela drug reimbursment

Uraemia requiring dialysis

5.7

30.0

100

L02BA01

ATC

tamoxifen; oral

50.4

29.4

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

29.2

KA3CT

NOMESCO Finland

Biopsy of kidney under CT guidance

+∞

29.2

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

29.2

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

9.3

29.2

Z3226

NOMESCO Finland

Physiotherapist

1.7

29.1

618

3903

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

66.5

28.9

TQW99

NOMESCO Finland

Other minor procedure on skin

2.7

28.9

154

577

Z3231

NOMESCO Finland

Registered nurse

1.6

28.9

902

6271

C50

ICD-10 Finland

Malignant neoplasm of breast

294.2

28.8

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

26.3

28.4

C02AC05

ATC

moxonidine; oral

2.3

28.3

227

1031

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

6.3

28.2

J01DB01

ATC

cefalexin; oral

1.6

28.2

2747

24118

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

28.2

H02AB06

ATC

prednisolone; systemic

1.5

27.6

1611

12748

M49.5*C79.5

ICD-10 Finland

Metastatic fracture of vertebra

+∞

27.1

PC5DT

NOMESCO Finland

Embolisation of tumor of kidney

+∞

27.1

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

27.1

D41.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified

75.7

26.8

JAH00

NOMESCO Finland

Laparotomy

3.2

26.8

105

331

L03AB04

ATC

interferon alfa-2a; parenteral

41.6

26.8

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

4.1

26.7

180

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

141.0

26.6

A06AD11

ATC

lactulose; oral

1.7

26.4

590

3767

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

7.6

26.3

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

7.0

26.3

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

26.1

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

26.1

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

26.1

KAC20

NOMESCO Finland

Nephroureterectomy

+∞

26.1

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

4.9

26.0

118

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

5.8

25.8

U06

ICPC

Haematuria

3.0

25.8

117

402

E87.5

ICD-10 Finland

Hyperkalaemia

3.2

25.7

105

339

L04AA06

ATC

mycophenolic acid; systemic

3.8

25.3

210

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

50.4

25.2

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.5

25.2

137

ZXE00

NOMESCO Finland

One hour or less

1.5

25.1

1190

8994

UJF32

NOMESCO Finland

Coloscopy

1.5

25.1

872

6181

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

25.0

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

25.0

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

25.0

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

25.0

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.1

24.8

240

1175

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

5.1

24.7

104

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

5.8

24.4

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

24.4

387

2242

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

48.7

24.3

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

24.2

504

3155

XX9XW, ,

NOMESCO Finland

7.1

24.2

N05CF01

ATC

zopiclone; oral

1.5

24.1

1101

8246

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

24.0

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

24.0

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

24.0

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.4

23.8

135

G04CA02

ATC

tamsulosin; oral

1.5

23.8

1105

8298

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.2

23.7

197

907

C08CA02

ATC

felodipine; oral

1.8

23.7

424

2543

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.4

23.7

170

735

128

Kela drug reimbursment

Cancers of female genital organs

241.5

23.7

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

241.5

23.7

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

241.5

23.7

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

125.8

23.6

C90.0

ICD-10 Finland

Multiple myeloma

125.8

23.6

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

26.9

23.5

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

5.3

23.4

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.4

23.4

137

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

6.7

23.4

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

33.6

23.3

KB1CG

NOMESCO Finland

Extensive MRI examination of urinary tract with high intensity magnet

47.0

23.3

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

8.8

23.3

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

9.7

23.2

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

22.9

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

22.9

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

22.9

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

22.9

PHN71

NOMESCO Finland

Excision of tumor mass from inferior vena cava

+∞

22.9

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

+∞

22.9

WX892

NOMESCO Finland

Monitored bed care

1.9

22.8

288

1550

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.6

22.8

207

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.1

22.7

153

B03XA01

ATC

erythropoietin; parenteral

5.0

22.7

100

G04BE03

ATC

sildenafil; oral

6.3

22.7

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

3.8

22.6

180

2395A

ICD-9 Finland

Neoplasm of unspecified nature, Other genito-urinary organs

19.1

22.6

WX600

NOMESCO Finland

Single shot through catheter

7.2

22.5

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

22.2

387

2302

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

22.2

988

7342

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

8.0

22.1

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.7

22.0

120

455

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

4.6

21.9

111

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

21.9

L02AE04

ATC

triptorelin; parenteral

+∞

21.9

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

21.9

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

21.9

M907, C6488,

ICD-10 Finland

+∞

21.9

ZXD05

NOMESCO Finland

Urgent procedure

1.5

21.8

985

7332

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

80.6

21.7

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

115.7

21.6

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

31.3

21.5

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

6.3

21.4

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

21.4

717

5018

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.0

21.3

257

1362

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

21.1

254

1345

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

3.2

21.0

263

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.4

21.0

228

B05DA

ATC

Isotonic solutions

5.2

21.0

B02AA02

ATC

tranexamic acid; systemic

1.8

20.9

318

1815

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

20.8

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

20.8

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

20.7

517

3381

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.5

20.6

133

548

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

211.2

20.6

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.4

20.5

144

617

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

7.8

20.4

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

5.4

20.4

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

6.9

20.4

JAH01

NOMESCO Finland

Laparoscopy

2.8

20.3

102

371

XJH00

NOMESCO Finland

Transanal ultrasonography

2.0

20.1

234

1224

JMA10

NOMESCO Finland

Transabdominal total splenectomy

16.1

20.1

M84.4

ICD-10 Finland

Pathological fracture, not elsewhere classified

17.4

20.0

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

18.9

19.9

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

19.8

L02BX02

ATC

degarelix; parenteral

+∞

19.8

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

19.8

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

19.8

L02AB02

ATC

medroxyprogesterone; systemic

15.4

19.7

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.9

19.7

311

X76

ICPC

Malignant neoplasm breast female

105.6

19.6

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

105.6

19.6

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

19.6

345

M10.9

ICD-10 Finland

Gout, unspecified

1.8

19.5

317

1845

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

5.2

19.4

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.5

19.2

123

505

3025

Kela drug reimbursment

Calcium carbonate

5.9

19.1

GDC00

NOMESCO Finland

Lobectomy of lung

26.2

19.1

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

4.2

19.1

120

XW000

NOMESCO Finland

Bone marrow biopsy

2.5

19.0

119

484

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.9

19.0

OAB42

NOMESCO Finland

Guidance related to known health problem

14.9

18.9

WX290

NOMESCO Finland

Other blockage of nerve

1.4

18.9

1184

9311

C08CA13

ATC

lercanidipine; oral

1.6

18.8

553

3753

KKB10

NOMESCO Finland

Excision of retroperitoneal tumour

70.2

18.7

JLC10

NOMESCO Finland

Distal pancreatectomy

28.0

18.7

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

6.8

18.7

PG1PT

NOMESCO Finland

Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified

5.6

18.7

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.3

18.6

135

587

A10BH05

ATC

linagliptin; oral

1.9

18.6

228

1214

J01EA01

ATC

trimethoprim; systemic

1.5

18.6

721

5185

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

23.8

18.6

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

4.1

18.5

127

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

3.2

18.5

232

D75

ICPC

Malignant neoplasm colon/rectum

30.2

18.3

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

6.3

18.0

B05DB

ATC

Hypertonic solutions

5.0

17.8

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

4.1

17.8

122

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

3.7

17.8

149

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

17.7

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

17.7

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

17.7

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

17.7

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

17.7

C79.0

ICD-10 Finland

Secondary malignant neoplasm of kidney and renal pelvis

+∞

17.7

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

17.7

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.8

17.6

314

U79

ICPC

Neoplasm urinary tract unspecified

95.5

17.6

M05BA02

ATC

clodronic acid; systemic

95.5

17.6

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

180.8

17.5

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.3

17.5

126

547

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

5.9

17.4

N03AX16

ATC

[U] pregabalin

1.5

17.4

721

5246

N18

ICD-10 Finland

Chronic kidney disease

3.4

17.4

185

TKW99

NOMESCO Finland

Other minor surgical procedure in urology

5.7

17.3

JN1AD

NOMESCO Finland

CT examination of upper part of abdomen

6.2

17.2

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

6.4

17.1

E0000UV, ,

ATC

1.4

17.1

1222

9782

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

31.6

17.0

H03AA01

ATC

levothyroxine sodium; systemic

1.5

17.0

661

4748

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

50.2

17.0

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

6.9

17.0

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

16.7

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

16.7

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

+∞

16.7

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

16.7

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

16.7

P01AB01

ATC

metronidazole; oral, rectal

1.4

16.7

1118

8850

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.2

16.6

147

695

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.1

16.6

162

796

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

90.5

16.6

L02BG03

ATC

anastrozole; oral

90.5

16.6

R33

ICD-10 Finland

Retention of urine

1.7

16.5

331

2042

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

170.8

16.5

N99.0

ICD-10 Finland

Postprocedural renal failure

40.3

16.3

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

40.3

16.3

L57.0

ICD-10 Finland

Actinic keratosis

1.7

16.2

286

1706

TJF80

NOMESCO Finland

Ostomy education

7.1

16.1

TKC20

NOMESCO Finland

Catheterisation of bladder

1.8

16.1

255

1473

H02AB09

ATC

hydrocortisone; systemic

2.8

15.9

275

D44.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Thyroid gland

4.3

15.9

Z2221

NOMESCO Finland

Medical doctor

1.4

15.7

778

5838

TK820

NOMESCO Finland

Peritoneal dialysis

5.5

15.7

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.9

15.6

245

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

15.6

C68.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of urinary organs

+∞

15.6

HAB99

NOMESCO Finland

Other partial excision of mammary gland

6.0

15.6

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

26.4

15.6

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

15.5

208

1142

D41

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour of urinary organs

160.7

15.5

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

4.5

15.4

Z2446

NOMESCO Finland

Social worker

1.9

15.3

183

967

SPAT1109

SPAT

Analgesia with portable analgesic pump

6.7

15.3

Z49.2

ICD-10 Finland

Other dialysis

4.2

15.3

J94.8

ICD-10 Finland

Other specified pleural conditions

3.1

15.2

196

ZXC20

NOMESCO Finland

Use of chemical agents

3.4

15.2

156

KWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in urological surgery

13.1

15.2

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

14.9

122

559

BAA60

NOMESCO Finland

Total thyroidectomy

3.4

14.9

158

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

3.1

14.9

204

D64.9

ICD-10 Finland

Anaemia, unspecified

1.6

14.7

395

2618

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

14.7

230

1324

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.6

14.7

331

2105

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

14.6

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

14.6

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

14.6

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

14.6

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

14.6

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

14.6

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

14.6

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

14.6

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

14.6

D77

ICPC

Malignant digestive neopl other/NOS

80.4

14.6

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

150.6

14.5

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

150.6

14.5

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

4.6

14.5

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

3.9

14.4

105

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.5

14.4

355

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

3.6

14.4

128

C09BA02

ATC

enalapril and diuretics; systemic

1.6

14.3

330

2108

WF099

NOMESCO Finland

Other radiotherapy

17.0

14.3

WX882

NOMESCO Finland

High dependency care

2.3

14.2

101

437

JFB43

NOMESCO Finland

Left hemicolectomy

6.4

14.1

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

12.0

14.1

L04AD02

ATC

tacrolimus; systemic

4.1

13.9

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

30.1

13.9

JLC30

NOMESCO Finland

Pancreatoduodenectomy

30.1

13.9

E89.6

ICD-10 Finland

Postprocedural adrenocortical(-medullary) hypofunction

53.5

13.8

N18.4

ICD-10 Finland

Chronic kidney disease, stage 4

3.3

13.8

151

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.2

13.7

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.1

13.6

124

594

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

75.4

13.6

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

13.6

169

906

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

13.5

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

13.5

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

13.5

NA049

NOMESCO Finland

Radiotherapy of methastasis in spine

+∞

13.5

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

13.5

YN1AD

NOMESCO Finland

CT examination of extremities for dose design of radiotherapy

+∞

13.5

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

13.5

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

13.5

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

13.5

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

13.5

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

13.5

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

13.5

C68.9

ICD-10 Finland

Malignant neoplasm: Urinary organ, unspecified

+∞

13.5

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

13.5

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

13.5

SPAT1254

SPAT

Administration of medicine

1.5

13.5

486

3428

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.1

13.5

184

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

140.5

13.5

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

16.2

13.4

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

3.6

13.4

120

V03AE03

ATC

lanthanum carbonate; oral

6.1

13.4

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

5.6

13.4

TK810

NOMESCO Finland

Hemofiltration

4.1

13.3

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

4.1

13.3

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

13.3

336

2196

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

3.3

13.3

155

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

3.0

13.2

186

WX002

NOMESCO Finland

Sedation and analgesia

1.4

13.2

601

4430

AA1AD

NOMESCO Finland

CT of head and brain

1.3

13.1

981

7839

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

40.2

13.1

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.4

13.1

141

C09AA02

ATC

enalapril; systemic

1.4

12.9

764

5885

E03.2

ICD-10 Finland

Hypothyroidism due to medicaments and other exogenous substances

5.6

12.9

N19

ICD-10 Finland

Unspecified kidney failure

1.9

12.9

151

794

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.0

12.8

134

676

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

50.2

12.8

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

2.3

12.8

100

451

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.5

12.8

315

N06DX01

ATC

memantine; oral

0.5

12.7

122

2344

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

12.7

1232

10212

C07AB02

ATC

metoprolol; systemic

1.4

12.7

790

6136

KC1GB

NOMESCO Finland

Cystography with X-ray

15.5

12.6

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

4.8

12.6

XX1AD

NOMESCO Finland

Other CT-examination

32.1

12.6

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

12.5

224

1340

323

Kela drug reimbursment

Sorafenib

+∞

12.5

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

12.5

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

+∞

12.5

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

12.5

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

12.5

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

12.5

JJB10

NOMESCO Finland

Atypcal resection of liver

+∞

12.5

AA049

NOMESCO Finland

Radiotherapy of metasthasis in the brain

+∞

12.5

PJD99

NOMESCO Finland

Excision of other lymph nodes

+∞

12.5

M90.7*C90.0

ICD-10 Finland

Pathological fracture in multiple myeloma

+∞

12.5

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

12.5

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

12.5

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

12.5

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

2.7

12.5

248

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.7

12.5

248

PJA10

NOMESCO Finland

Exploration of lymph nodes

5.2

12.5

212

Kela drug reimbursment

Gout

2.3

12.5

386

GDA20

NOMESCO Finland

Excision of lesion of lung

24.4

12.5

GDB10

NOMESCO Finland

Wedge resection of lung

20.1

12.4

L02BG06

ATC

exemestane; oral

130.4

12.4

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

130.4

12.4

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.0

12.4

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

12.3

124

617

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.9

12.3

205

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

12.3

1462

12432

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

3.2

12.3

147

J01CA04

ATC

amoxicillin; systemic

1.3

12.3

2524

23022

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

12.2

634

4778

PC1CC

NOMESCO Finland

Very extensive angiography of aorta and abdominal arteries

6.0

12.1

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.8

12.0

208

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.7

12.0

UKB02

NOMESCO Finland

Retrograde ureteroscopy

3.6

12.0

110

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

5.7

11.9

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

11.9

1365

11538

KEB00

NOMESCO Finland

Biopsy of prostate

4.3

11.9

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

13.4

11.9

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.6

11.9

106

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

11.9

740

5742

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.8

11.8

204

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

3.0

11.7

167

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.3

11.7

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.5

11.7

304

JFB46

NOMESCO Finland

Resection of sigmoid colon

3.5

11.7

112

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

16.4

11.7

D64.8

ICD-10 Finland

Other specified anaemias

2.6

11.6

263

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

3.0

11.6

168

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

12.6

11.6

KB1DG

NOMESCO Finland

Very extensive MRI of urinary tract

65.2

11.6

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

65.2

11.6

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

19.0

11.6

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

8.6

11.5

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

10.1

11.5

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

5.7

11.5

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

11.5

1888X

ICD-9 Finland

Malignant neoplasm of bladder, Other specified sites of bladder

+∞

11.5

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

11.5

U77

ICPC

Malignant neopl urinary tract other

+∞

11.5

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

11.5

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

11.5

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

11.5

YX9AW, ,

NOMESCO Finland

+∞

11.5

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

11.5

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

11.5

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

11.5

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

+∞

11.5

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

11.5

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

11.5

390

Kela drug reimbursment

Ibrutinib

+∞

11.5

Z80.5

ICD-10 Finland

Family history of malignant neoplasm of urinary tract

120.4

11.4

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

120.4

11.4

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

120.4

11.4

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.6

11.4

260

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

3.1

11.4

149

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

11.3

533

3948

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

17.1

11.2

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.6

11.2

257

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

11.1

909

7333

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.9

11.1

173

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

8.6

11.0

D34

ICD-10 Finland

Benign neoplasm of thyroid gland

5.0

11.0

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

2.7

11.0

224

WW200, ,

SPAT

0.7

11.0

418

5739

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.5

11.0

283

D48.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage

3.3

10.9

127

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

43.4

10.9

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

43.4

10.9

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

10.9

1160

9687

L04AD01

ATC

ciclosporin; systemic

2.8

10.9

197

3AC01, ,

NOMESCO Finland

3.5

10.9

103

TPX15

NOMESCO Finland

Removal of vascular injection port

11.9

10.8

M10.3

ICD-10 Finland

Gout due to impairment of renal function

4.2

10.8

WVA20

NOMESCO Finland

Medicine administration

2.4

10.8

304

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

10.7

487

3580

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

17.8

10.7

7124

FHL

Nephrectomy (simple

21.5

10.7

XF612

NOMESCO Finland

Measurement of central venous pressure

12.9

10.6

R11

ICD-10 Finland

Nausea and vomiting

1.6

10.6

229

1442

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

4.2

10.5

C10AA07

ATC

rosuvastatin; oral

0.8

10.5

719

8999

PC5SC

NOMESCO Finland

Selective angiography of kidney artery with X-ray

10.0

10.5

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.0

10.5

146

N05BA04

ATC

oxazepam; oral

1.3

10.5

758

6001

NF3AA

NOMESCO Finland

Femur X-ray examination

2.4

10.5

314

C07AB07

ATC

bisoprolol; oral

1.3

10.4

1811

16015

Q85.82

ICD-10 Finland

of Hipple-Lindau syndrome

110.3

10.4

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

110.3

10.4

C66

ICD-10 Finland

Malignant neoplasm of ureter

+∞

10.4

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

+∞

10.4

1CD02, ,

NOMESCO Finland

+∞

10.4

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

10.4

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

10.4

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

10.4

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

10.4

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

10.4

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

10.4

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

10.4

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

10.4

C82.2

ICD-10 Finland

Follicular lymphoma grade III, unspecified

+∞

10.4

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

16.1

10.3

GDB21

NOMESCO Finland

Thoracoscopic segmental resection of lung

32.6

10.3

WX250

NOMESCO Finland

Intercostal blockade

18.8

10.2

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

2.1

10.2

440

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

4.6

10.2

A46

ICD-10 Finland

Erysipelas

1.4

10.2

507

3783

WPB10

NOMESCO Finland

Making a convalescent care decision

13.1

10.1

KED22

NOMESCO Finland

Transurethral resection of prostate

1.6

10.1

229

1457

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.6

10.0

217

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

11.3

10.0

J01MA14

ATC

moxifloxacin; systemic

1.6

10.0

262

1724

C09CA01

ATC

losartan; oral

1.3

10.0

891

7258

A07AA02

ATC

nystatin; oral

1.7

10.0

168

990

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

3.7

10.0

TKE10

NOMESCO Finland

Puncture of prostate

40.2

10.0

K46.9

ICD-10 Finland

Unspecified abdominal hernia without obstruction or gangrene

4.1

9.9

L04AA01

ATC

[U] ciclosporin

2.9

9.9

151

A12AA12

ATC

[U] calcium acetate

7.6

9.9

SPAT1262

SPAT

Handing over of treatment supplies

1.4

9.9

588

4518

KBV10

NOMESCO Finland

Removal of stent from ureter

3.9

9.8

N25.0

ICD-10 Finland

Renal osteodystrophy

5.2

9.8

C03AA03

ATC

hydrochlorothiazide; oral

1.5

9.8

330

2292

N28.9

ICD-10 Finland

Disorder of kidney and ureter, unspecified

8.1

9.8

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

4.0

9.8

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.4

9.7

288

JFF23

NOMESCO Finland

Transversostomy

5.3

9.6

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

7.8

9.6

N04.1

ICD-10 Finland

Nephrotic syndrome, focal and segmental glomerular lesions

11.4

9.5

KDE20

NOMESCO Finland

Removal of foreign body from urethra

4.4

9.5

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

9.5

360

TGD00

NOMESCO Finland

Needle biopsy of lung

10.0

9.5

WZC15, ,

NOMESCO Finland

15.0

9.5

JKA20

NOMESCO Finland

Cholecystectomy

2.1

9.5

447

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

100.3

9.4

XX6LT

NOMESCO Finland

Coagulation of tumour with radiological guidance

100.3

9.4

JJ6LT

NOMESCO Finland

Coagulation of focal hepatic lesion under ultrasound guidance

100.3

9.4

9680/3-C64.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of kidney, NOS

+∞

9.4

C69.30

ICD-10 Finland

Malignant tumor of the chorioidea without histology

+∞

9.4

L02BB04

ATC

enzalutamide; oral

+∞

9.4

1891X

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,EI HIST VAHV]

+∞

9.4

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

9.4

L01AX03

ATC

temozolomide; systemic

+∞

9.4

1XC17, ,

NOMESCO Finland

+∞

9.4

XX1XN

NOMESCO Finland

Other isotope examination

+∞

9.4

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

9.4

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

9.4

PHN70

NOMESCO Finland

Plastic repair of inferior vena cava

+∞

9.4

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

9.4

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

9.4

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

9.4

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

9.4

1890C

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,MUU/TARK MÄÄR SYÖPÄ]

+∞

9.4

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.6

9.4

A02BC01

ATC

omeprazole; systemic

1.3

9.4

850

6930

D13.4

ICD-10 Finland

Benign neoplasm: Liver

5.2

9.4

R06.0

ICD-10 Finland

Dyspnoea

1.3

9.3

861

7038

TPH40

NOMESCO Finland

Insertion of a long peripheral venous catheter

4.7

9.3

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.5

9.3

232

ZQZ00

NOMESCO Finland

Treatment of several skin areas

9.5

9.3

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.2

9.2

115

N30.9

ICD-10 Finland

Cystitis, unspecified

1.7

9.2

172

1044

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.1

9.2

412

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

3.9

9.1

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.7

9.1

147

856

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

3.0

9.1

126

S15

ICPC

Foreign body in skin

1.7

9.1

179

1102

GDA21

NOMESCO Finland

Thoracoscopic excision of lesion of lung

15.6

9.0

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

9.0

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

7.0

9.0

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.8

8.9

149

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

24.1

8.9

R60.0

ICD-10 Finland

Localized oedema

1.4

8.9

387

2823

K45.8

ICD-10 Finland

Other specified abdominal hernia without obstruction or gangrene

4.3

8.9

ZX121

NOMESCO Finland

Central venous catheter

12.5

8.9

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

8.0

8.8

A28

ICPC

Limited function/disability NOS

1.3

8.8

601

4706

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

8.8

532

4093

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

2.4

8.8

238

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.0

8.8

488

A10AE04

ATC

insulin glargine; parenteral

1.4

8.7

330

2345

S77

ICPC

Malignant neoplasm of skin

14.0

8.7

PC5NT

NOMESCO Finland

Endovascular embolisation for kidney bleeding with radiological guidance

50.1

8.7

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

50.1

8.7

C20

ICD-10 Finland

Malignant neoplasm of rectum

50.1

8.7

JL1AT

NOMESCO Finland

Biopsy of pancreas with ultrasound guidance

50.1

8.7

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

50.1

8.7

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.6

8.6

187

1178

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

3.1

8.6

109

C09DA01

ATC

losartan and diuretics; oral

1.4

8.6

356

2571

KA1FN

NOMESCO Finland

Isotope renography

4.8

8.6

ZX100

NOMESCO Finland

Oral

2.8

8.6

147

K65.0

ICD-10 Finland

Acute peritonitis

2.8

8.6

147

A12BA01

ATC

potassium chloride; oral

1.6

8.6

172

1064

306

Kela drug reimbursment

Erythropoietin and darbepoetin

9.0

8.5

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.6

8.5

196

1254

JFB00

NOMESCO Finland

Partial resection of small intestine

2.7

8.5

159

H02AB07

ATC

prednisone; oral

1.4

8.5

394

2904

R84

ICPC

Malignant neoplasm bronchus/lung

20.1

8.5

Q60.0

ICD-10 Finland

Renal agenesis, unilateral

20.1

8.5

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

90.3

8.4

PHC70

NOMESCO Finland

Suture of inferior vena cava

90.3

8.4

DAB00

NOMESCO Finland

Excision of lesion of auricle

3.9

8.4

N43.3

ICD-10 Finland

Hydrocele, unspecified

2.0

8.4

406

J01FF01

ATC

clindamycin; systemic

1.3

8.4

781

6377

A03

ICPC

Fever

1.4

8.4

351

2542

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

4.5

8.4

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

4.9

8.4

Z93.3

ICD-10 Finland

Colostomy status

4.9

8.4

WX610

NOMESCO Finland

Patient controlled analgesia

4.7

8.3

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

2.7

8.3

155

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

8.3

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

8.3

L01CB01

ATC

etoposide; systemic

+∞

8.3

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

8.3

5BX04, ,

NOMESCO Finland

+∞

8.3

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

8.3

C50.52

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, lobular tumor

+∞

8.3

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

8.3

OAA41

NOMESCO Finland

Health check based on individual needs

+∞

8.3

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

8.3

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

8.3

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

+∞

8.3

C88.0

ICD-10 Finland

Waldenström macroglobulinaemia

+∞

8.3

C67.0

ICD-10 Finland

Malignant neoplasm: Trigone of bladder

+∞

8.3

1512

Kela drug reimbursment

Ibrutinib

+∞

8.3

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

8.3

Z08.2

ICD-10 Finland

Follow-up examination after chemotherapy for malignant neoplasm

+∞

8.3

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

8.3

L01CA04

ATC

vinorelbine; systemic

+∞

8.3

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

8.3

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

8.3

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

8.3

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

+∞

8.3

KE002

NOMESCO Finland

Radical radiotherapy of prostata and seminal vesicles

+∞

8.3

8120/3-C65.9

ICD-O-3

Transitional cell carcinoma, NOS, of renal pelvis

+∞

8.3

C73.92

ICD-10 Finland

Follicular carcinoma of the thyroid gland

+∞

8.3

105

Kela drug reimbursment

Adrenal cortical hypofunction

8.5

8.3

ZXC50

NOMESCO Finland

Cryotherapy

2.2

8.3

328

J01CA08

ATC

pivmecillinam; oral

1.3

8.3

885

7351

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

2.8

8.3

139

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

8.2

290

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

2.8

8.2

145

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

8.2

441

3333

A26

ICPC

Fear of cancer, NOS

4.4

8.1

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

8.1

227

1518

1XC02, ,

NOMESCO Finland

4.5

8.1

WX202

NOMESCO Finland

Supraclavicular plexus blockade

2.6

8.1

175

KAB00

NOMESCO Finland

Biopsy of kidney or pelvis of kidney

33.4

8.1

7121

FHL

Removal of local change or renal resection (eg cyst)

33.4

8.1

H05BX02

ATC

paricalcitol; systemic

17.2

8.1

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.6

8.0

170

1066

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

10.0

8.0

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

6.3

8.0

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.6

8.0

176

KBV00

NOMESCO Finland

Insertion of stent into ureter

4.1

8.0

E21.0

ICD-10 Finland

Primary hyperparathyroidism

2.4

7.9

213

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

7.8

7.9

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.5

7.9

1189

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.0

7.9

451

C07AG02

ATC

carvedilol; oral

1.5

7.8

219

1466

GEA20

NOMESCO Finland

Mediastinoscopy with excision of lesion

10.8

7.8

N20.1

ICD-10 Finland

Calculus of ureter

1.8

7.7

121

700

KWA00

NOMESCO Finland

Repair of wound dehiscence in urological surgery

45.1

7.7

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

7.7

114

649

PBU84

NOMESCO Finland

Plastic repair of arteriovenous fistula from artery of upper extremity

8.0

7.6

M10

ICD-10 Finland

Gout

1.6

7.6

167

1058

KWW96

NOMESCO Finland

Other reoperation in urological surgery

25.1

7.6

E21.09

ICD-10 Finland

Other primary hyperparathyroidism

2.3

7.5

224

C09CA03

ATC

valsartan; oral

1.4

7.4

313

2269

7323

FHL

Electrosection of TU bladder wall change

80.3

7.4

G04BE30

ATC

drugs used in erectile dysfunction - combinations

80.3

7.4

NAR00

NOMESCO Finland

Complete excision of tumour of bone or cartilage of spine, unspecified

80.3

7.4

L02AE03

ATC

goserelin; implant

7.6

7.4

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

7.4

117

680

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.9

7.3

470

C67

ICD-10 Finland

Malignant neoplasm of bladder

+∞

7.3

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

7.3

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

+∞

7.3

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

7.3

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

7.3

C84.0

ICD-10 Finland

Mycosis fungoides

+∞

7.3

8070/3-C02.1

ICD-O-3

Squamous cell carcinoma, NOS, of border of tongue

+∞

7.3

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

7.3

PC6FT

NOMESCO Finland

Endovascular very extensive embolisation of spinal lesion

+∞

7.3

KKB11

NOMESCO Finland

Percutaneous endoscopic excision of retroperitoneal tumour

+∞

7.3

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

7.3

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

+∞

7.3

8890/3-C64.9

ICD-O-3

Leiomyosarcoma, NOS, of kidney, NOS

+∞

7.3

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

7.3

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

7.3

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

7.3

L01EX02

ATC

sorafenib; oral

+∞

7.3

D63.0

ICD-10 Finland

Anaemia in neoplastic disease

+∞

7.3

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

7.3

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

7.3

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

7.3

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

7.3

K62.7

ICD-10 Finland

Radiation proctitis

+∞

7.3

8316/3-C64.9

ICD-O-3

Cyst-associated renal cell carcinoma of kidney, NOS

+∞

7.3

M90.7

ICD-10 Finland

Fracture of bone in neoplastic disease

+∞

7.3

8318/3-C64.9

ICD-O-3

Renal cell carcinoma, sarcomatoid of kidney, NOS

+∞

7.3

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

7.3

N02AA03

ATC

hydromorphone; systemic, rectal

10.9

7.3

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

6.2

7.2

XX9KE

NOMESCO Finland

Ultrasound examination with contrast

15.8

7.2

N06DA02

ATC

donepezil; oral

0.6

7.2

105

1781

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.3

7.2

425

3256

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

2.5

7.2

174

R04.2

ICD-10 Finland

Haemoptysis

1.7

7.1

120

709

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

30.1

7.1

C02DE10, ,

ATC

2.3

7.1

211

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

7.1

442

3412

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

7.1

418

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

3.8

7.1

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

7.1

370

SPAT1255

SPAT

Intravenous administration of medicine

1.5

7.1

201

1351

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

5.6

7.1

BBA30

NOMESCO Finland

Excision of lesion of parathyroid gland

2.9

7.0

112

SPAT1263

SPAT

Sampling

1.2

7.0

1230

10743

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

4.2

7.0

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

4.2

7.0

QBA10

NOMESCO Finland

Incision of skin of trunk

3.1

7.0

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.1

7.0

317

KFD20

NOMESCO Finland

Excision of hydrocele of testis

2.3

7.0

232

1530

FHL

Urethrocystoscopy

2.1

7.0

291

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

4.4

7.0

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

13.8

6.9

GD2SN

NOMESCO Finland

Lung ventilation SPECT

3.1

6.9

E04.9

ICD-10 Finland

Nontoxic goitre, unspecified

2.2

6.9

240

K56.7

ICD-10 Finland

Ileus, unspecified

2.2

6.9

240

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

6.8

294

2139

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

8.3

6.8

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.9

6.8

418

C44.40

ICD-10 Finland

Malignant tumor of the skin of the scalp and neck without histology

40.1

6.8

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

40.1

6.8

T73

ICPC

Neoplasm endocrine other/unspecified

40.1

6.8

D30.1

ICD-10 Finland

Benign neoplasm: Renal pelvis

40.1

6.8

PC5ET

NOMESCO Finland

Extensive embolisation of tumor of kidney

40.1

6.8

JN4ED

NOMESCO Finland

Body CT examination with specail preparation

40.1

6.8

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

5.6

6.7

KA3EB

NOMESCO Finland

Antegrade pyelography

5.6

6.7

JLC11

NOMESCO Finland

Laparoscopic distal pancreatectomy

16.7

6.7

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

3.9

6.7

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

1.6

6.7

151

964

DAB10

NOMESCO Finland

Partial excision of auricle

22.5

6.7

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

22.5

6.7

WX1BG

NOMESCO Finland

Total body MRI with high intensity magnet

22.5

6.7

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

22.5

6.7

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

22.5

6.7

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

6.7

200

1360

A29

ICPC

General symptom/complaint other

1.4

6.6

370

2809

ED1AA

NOMESCO Finland

Mandibular X-ray examination

4.0

6.6

ZX136

NOMESCO Finland

Intravesicalis

4.0

6.6

K92.1

ICD-10 Finland

Melaena

1.5

6.6

170

1118

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

2.7

6.6

122

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

2.9

6.6

100

JN3BG

NOMESCO Finland

MRI examination of abdomen with high intensity magnet

10.0

6.5

N20.9

ICD-10 Finland

Urinary calculus, unspecified

1.9

6.5

424

C02CA01

ATC

prazosin; oral

2.0

6.5

354

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.3

6.5

195

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

2.3

6.5

195

E66.8

ICD-10 Finland

Other obesity

1.7

6.5

112

668

JAL30

NOMESCO Finland

Omentectomy

5.7

6.4

23730

ICD-8 Finland

Neoplasm of unspecified nature of other genito-urinary organs, Kidney, except pelvis

70.0

6.4

5639

FHL

Other measure in this category

70.0

6.4

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

70.0

6.4

KAD10

NOMESCO Finland

Heminephrectomy

70.0

6.4

R52.9

ICD-10 Finland

Pain, unspecified

1.4

6.4

257

1847

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.1

6.4

274

WPA44

NOMESCO Finland

Nursing home for palliative care

14.3

6.4

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

1.6

6.4

125

771

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

6.4

568

4601

N30.0

ICD-10 Finland

Acute cystitis

1.3

6.4

385

2959

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.1

6.4

268

ELB40

NOMESCO Finland

Partial parotidectomy

2.6

6.3

142

T92

ICPC

Gout

1.9

6.3

435

KCB00

NOMESCO Finland

Biopsy of bladder

6.5

6.3

KA1AE, ,

SPAT

8.1

6.3

JG1CG

NOMESCO Finland

Extensive MRI of rectum

11.0

6.3

UKA02

NOMESCO Finland

Retrograde ureteronephroscopy

5.5

6.3

JN1CM

NOMESCO Finland

Upper part of abdomen extensive MRI examination with 3 Tesla magnet

9.3

6.3

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

9.3

6.3

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.7

6.3

111

667

5702

FHL

Local lymph node removal (eg armpit, groin)

18.0

6.3

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

+∞

6.2

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

6.2

C76.0

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Head, face and neck

+∞

6.2

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

6.2

L01XE27

ATC

[U] ibrutinib

+∞

6.2

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

+∞

6.2

8070/3-C44.2

ICD-O-3

Squamous cell carcinoma, NOS, of external ear

+∞

6.2

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

+∞

6.2

JN3GE

NOMESCO Finland

Intraoperative ultrasound examination of abdomen

+∞

6.2

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

6.2

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

+∞

6.2

C21.0

ICD-10 Finland

Malignant neoplasm: Anus, unspecified

+∞

6.2

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

6.2

C68

ICD-10 Finland

Malignant neoplasm of other and unspecified urinary organs

+∞

6.2

1899X

ICD-9 Finland

Malignant neoplasm of kidney and other and unspecified urinary organs, Urinary organ, site unspecified[NEOPLASMA MAL ORG URIN NUD,EI HIST VAHV]

+∞

6.2

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

+∞

6.2

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

6.2

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

+∞

6.2

8936/3-C16.9

ICD-O-3

Gastrointestinal stromal tumor of stomach, NOS

+∞

6.2

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

6.2

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

6.2

8140/3-C16.0

ICD-O-3

Adenocarcinoma, NOS, of cardia, NOS

+∞

6.2

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

6.2

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

6.2

L02BX03

ATC

abiraterone; oral

+∞

6.2

CKE65

NOMESCO Finland

Removal of brachytherapeutic plate from eye

+∞

6.2

JN5AQ

NOMESCO Finland

SPECT of thyroid metastasis with low-dose CT

+∞

6.2

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

+∞

6.2

C79.32

ICD-10 Finland

Secondary malignant tumor of the brainstem

+∞

6.2

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

6.2

WE198

NOMESCO Finland

Palliative cystotatic therapy

+∞

6.2

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

6.2

7126

FHL

Nephroureterectomy

+∞

6.2

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

+∞

6.2

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

6.2

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

6.2

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

+∞

6.2

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

6.2

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

+∞

6.2

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

+∞

6.2

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

6.2

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

6.2

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

+∞

6.2

C16.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of stomach

+∞

6.2

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

+∞

6.2

KAC21

NOMESCO Finland

Percutaneous endoscopic nephroureterectomy

+∞

6.2

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

6.2

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

6.2

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

26.7

6.2

ZX022

NOMESCO Finland

LDR radiotherapy within tissue

26.7

6.2

GD2CT

NOMESCO Finland

Cytology of the lungs with CT guidance

26.7

6.2

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

6.2

1925

17659

Z94.1

ICD-10 Finland

Heart transplant status

7.0

6.2

C08CA05

ATC

nifedipine; systemic

1.5

6.2

205

1422

U28

ICPC

Limited function/disability (U)

2.4

6.2

162

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

6.3

6.2

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

5.3

6.1

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.7

6.1

103

610

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.2

6.1

822

6976

RS222, ,

NOMESCO Finland

2.5

6.1

145

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.8

6.1

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

1.8

6.1

441

N17.8

ICD-10 Finland

Other acute renal failure

2.3

6.1

182

ZZA50

NOMESCO Finland

Full thickness skin graft

12.5

6.1

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

2.3

6.1

201

G30.1

ICD-10 Finland

Alzheimer disease with late onset

0.6

6.1

116

1836

M10.0

ICD-10 Finland

Idiopathic gout

1.6

6.1

129

813

N07BC02

ATC

methadone; systemic

6.7

6.0

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

10.0

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3037121) Protein [Mass/volume] in Urine

576

956

6.96

307.65

2.9

2.7

0.27

0.32

g/l

0.92

387

348

(4035726) Immunohistochemistry procedure

739

701

12.95

307.65

1.4

1.2

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2321

11883

3.59

303.86

3.2

2.4

—

(40768804) Tissue Pathology biopsy report

1791

8240

3.29

270.62

2.5

1.6

—

(3044640) Blood type and Crossmatch panel - Blood

1714

7845

3.22

258.42

3.0

2.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

2204

11903

3.13

244.39

7.9

3.9

34.26

35.36

g/l

14.97

2088

10841

(3020779) Urea [Moles/volume] in Serum or Plasma

860

2711

3.84

232.51

9.2

7.3

11.47

11.08

mmol/l

0.79

819

2560

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

891

2915

3.72

227.57

4.3

2.8

235.05

238.46

u/l

0.30

869

2696

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

620

1562

4.57

227.36

7.7

10.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

886

2893

3.72

226.89

7.4

7.7

120.06

122.67

g/l

3.43

870

2819

(3016502) Oxygen saturation in Arterial blood

934

3227

3.54

218.61

7.1

7.2

96.63

94.99

15.41

906

3105

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2263

12972

2.94

214.78

10.4

5.5

1.21

mmol/l

0.38

2148

11573

(3003396) Base excess in Arterial blood by calculation

970

3534

3.37

207.52

7.1

6.9

-0.21

1.24

mmol/l

24.76

794

2767

(3002582) Erythrocytes [#/volume] in Urine

1711

8592

2.86

206.59

4.8

3.1

79.07

71.62

e6/l

0.13

1434

6580

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2313

13609

2.89

205.38

11.5

3.8

10.93

12.41

umol/l

5.14

2233

12710

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

969

3554

3.35

204.76

7.1

6.9

5.29

5.05

kpa

13.62

940

3387

(3027801) Oxygen [Partial pressure] in Arterial blood

968

3553

3.34

204.25

7.1

6.9

13.69

11.44

kpa

28.96

938

3384

(3000991) Gas panel - Venous blood

773

2461

3.71

203.79

9.2

7.8

—

(3002256) Pathology report gross observation

665

1923

4.00

201.43

1.4

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

986

3689

3.29

201.25

9.1

5.7

1.09

1.04

mmol/l

4.90

930

3380

(3030467) Casts [#/volume] in Urine by Automated count

1599

7876

2.82

198.42

4.6

3.0

0.30

0.47

e6/l

1.28

1338

5991

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

561

1456

4.37

196.59

3.0

1.4

10.36

2.73

ug/l

1.34

445

1076

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1332

6020

2.90

193.69

2.9

2.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

556

1492

4.21

185.90

8.2

9.1

23.37

24.34

mmol/l

10.80

548

1432

(36304419) Bacteria [Presence] in Urine

1528

7578

2.74

183.92

4.5

3.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

2751

18358

2.99

181.77

6.0

4.4

604.64

2201.68

e6/l

1.63

290

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2324

14323

2.70

177.73

12.1

5.9

1.21

mmol/l

1.36

1976

12142

(3018095) Leukocytes [#/volume] in Urine

1801

9918

2.60

172.22

5.4

3.5

65.20

108.85

e6/l

2.05

1477

7079

(3023368) Bacteria identified in Blood by Culture

1541

8020

2.59

163.78

5.3

3.9

—

(3000850) Epithelial cells [#/volume] in Urine

1267

6012

2.69

162.57

3.5

2.5

3.48

4.44

e6/l

3.23

1170

5341

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2973

21302

3.08

160.50

14.3

5.4

82.60

76.46

u/l

13.18

2889

19656

(3014111) Lactate [Moles/volume] in Serum or Plasma

721

2611

3.19

151.39

7.7

6.5

1.15

1.44

mmol/l

17.62

709

2535

(3013650) Neutrophils [#/volume] in Blood by Automated count

2307

14847

2.49

150.07

13.9

6.2

4.35

4.38

e9/l

0.17

2031

12720

(3012095) Magnesium [Moles/volume] in Serum or Plasma

964

4167

2.78

146.43

4.7

2.6

0.81

0.82

mmol/l

2.29

923

3819

(3026782) Osmolality of Urine

1183

5711

2.58

143.45

4.1

2.8

534.80

550.24

mosm/kgh2o

1.88

1063

4830

(3013826) Glucose [Moles/volume] in Serum or Plasma

2523

17166

2.50

141.20

7.1

4.5

6.93

6.90

mmol/l

0.34

2450

16064

(3035637) Corticotropin [Mass/volume] in Plasma

188

240

8.20

138.49

1.5

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

987

4438

2.67

137.65

4.2

2.8

1.75

1.99

e6/l

0.43

599

2456

(3015377) Calcium [Moles/volume] in Serum or Plasma

1576

8809

2.38

137.26

6.5

2.1

2.36

2.35

mmol/l

3.28

1435

7357

(3018418) pH of Serum or Plasma

1494

8217

2.38

134.32

7.6

3.3

7.39

7.40

5.45

339

1415

(3022217) INR in Platelet poor plasma by Coagulation assay

2217

14529

2.33

130.60

17.1

19.3

1.24

1.38

inr

10.48

638

4039

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1028

4849

2.56

128.76

3.9

2.6

0.77

1.18

e6/l

3.28

639

2852

(3033658) Prothrombin time (PT) actual/Normal

1228

6581

2.30

113.19

5.4

3.6

90.80

84.56

13.27

1209

6401

(3037467) Urinalysis macro (dipstick) panel - Urine

2666

19489

2.34

112.88

6.1

4.2

—

(3049717) Cytology report of Urine Cyto stain

363

1018

3.85

112.06

2.3

1.8

—

(3026008) Bacteria identified in Urine by Culture

1465

8498

2.20

110.74

3.3

3.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1479

8836

2.13

101.46

4.2

2.3

67.49

60.46

u/l

1.41

1394

8102

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

557

2244

2.75

93.26

6.1

3.9

132.77

97.46

ng/l

8.17

495

1892

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

233

540

4.54

92.61

2.7

1.8

11935.79

24.24

u/ml

0.56

202

429

(3018677) aPTT in Platelet poor plasma by Coagulation assay

908

4638

2.27

90.73

2.2

2.0

30.10

30.12

0.04

900

4494

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

973

5118

2.23

90.48

5.8

2.2

2.49

2.45

mmol/l

16.03

888

4339

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

804

3956

2.32

87.42

4.0

2.7

20.09

22.67

6.34

690

3330

(3004789) Transferrin [Mass/volume] in Serum or Plasma

838

4227

2.27

85.71

3.9

2.6

2.11

2.28

g/l

15.34

789

3887

(3022948) Iron [Moles/volume] in Serum or Plasma

879

4575

2.21

82.95

3.9

2.6

10.71

12.89

umol/l

16.39

829

4218

(3036481) Cortisol [Moles/volume] in Serum or Plasma

531

2237

2.61

80.63

5.1

1.8

393.91

363.08

nmol/l

2.88

510

2013

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

308

985

3.32

77.12

2.8

3.2

0.36

0.33

u/ml

0.68

142

589

(40760892) CBC W Ordered Manual Differential panel - Blood

1810

12473

1.89

75.68

7.6

5.7

—

(3019069) Monocytes/100 leukocytes in Blood

1810

12546

1.87

73.59

7.4

5.9

8.74

8.87

0.96

1715

11563

(3022096) Basophils/100 leukocytes in Blood

1761

12111

1.87

73.30

7.0

5.7

0.63

0.67

2.30

1669

11141

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

162

340

4.94

72.50

1.3

1.2

—

(3006504) Eosinophils/100 leukocytes in Blood

1798

12477

1.86

72.45

7.1

5.6

2.87

3.01

1.61

1704

11488

(3002030) Lymphocytes/100 leukocytes in Blood

1832

12821

1.86

71.53

7.1

5.7

24.90

26.77

9.73

1734

11862

(3001604) Monocytes [#/volume] in Blood

1898

13470

1.85

70.44

6.7

5.3

0.63

0.62

e9/l

0.96

1633

11545

(3006315) Basophils [#/volume] in Blood

1901

13521

1.84

69.82

6.8

5.3

0.04

e9/l

0.94

1637

11589

(3019198) Lymphocytes [#/volume] in Blood

1929

13827

1.83

68.63

6.9

5.4

1.84

1.83

e9/l

0.09

1690

12067

(3013115) Eosinophils [#/volume] in Blood

1945

13979

1.83

68.58

7.0

5.5

0.20

0.21

e9/l

0.68

1690

12104

(3003694) ABO and Rh group [Type] in Blood

1089

6534

1.95

67.79

1.4

1.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

22.03

67.59

2.4

1.0

32.52

12.87

u/ml

0.83

(3018010) Neutrophils/100 leukocytes in Blood

1799

12680

1.82

67.11

7.0

5.6

59.80

58.06

7.36

1705

11729

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

231

677

3.57

66.14

4.8

3.2

1.85

1.70

mg/l

1.53

212

599

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

477

2123

2.43

63.61

2.0

0.22

0.20

g/l

3.49

446

1916

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1279

8264

1.84

62.20

4.6

2.7

32.33

36.50

u/l

0.99

1224

7749

(40768800) Prostate Pathology biopsy report

105

174

6.18

60.71

1.2

1.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

849

4912

1.95

57.41

2.0

1.8

—

(40758558) Short blood count panel - Blood

1019

6327

1.84

55.06

10.6

4.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

546

2769

2.14

52.75

3.1

2.2

7.96

8.27

umol/l

0.14

487

2367

(3009214) Lutropin [Units/volume] in Serum or Plasma

170

474

3.71

52.33

1.5

1.4

16.15

8.05

u/l

5.42

131

391

(3002032) Base excess in Venous blood by calculation

583

3041

2.09

52.28

6.4

3.6

1.20

1.96

mmol/l

5.24

491

2553

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

349

1474

2.51

51.71

7.3

4.0

23.61

24.14

mmol/l

2.57

341

1432

(3035350) Ketones [Presence] in Urine by Test strip

1852

13815

1.69

51.28

5.1

3.7

0.00

estimate

1.74

464

2548

(3021447) Carbon dioxide [Partial pressure] in Venous blood

580

3049

2.07

50.83

6.3

3.6

5.85

5.84

kpa

0.10

566

2941

(3012544) pH of Venous blood

595

3173

2.04

50.10

6.2

3.6

7.39

7.37

—

(3009261) Glucose [Presence] in Urine by Test strip

1857

13918

1.68

50.03

5.2

3.7

0.01

estimate

0.07

442

2228

(3019060) Gas panel - Arterial blood

455

2197

2.22

49.57

5.0

4.8

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

20.20

49.49

7.7

1.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

499

2520

2.13

48.48

2.9

1.6

65.54

66.75

g/l

2.69

465

2224

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

141

367

3.96

47.86

4.1

5.9

815.13

997.10

iu/ml

0.10

(3021601) Nitrite [Presence] in Urine by Test strip

1828

13762

1.65

47.45

6.8

4.9

0.00

estimate

-0.00

451

2343

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

449

2202

2.18

46.93

2.0

1.5

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

412

1957

2.24

46.58

1.8

1.6

—

(1616796) Gas panel - Central venous blood

194

635

3.17

46.42

4.3

4.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

428

2085

2.19

45.43

2.0

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1186

8073

1.69

44.76

3.6

2.5

2581.70

5820.14

umol/l

2.29

1041

6913

(3039000) Anion gap in Blood

198

684

3.00

43.16

6.3

7.0

11.21

11.38

mmol/l

0.36

182

615

(3018572) Chloride [Moles/volume] in Blood

198

684

3.00

43.16

6.3

7.0

105.84

104.87

mmol/l

2.89

182

615

(3008152) Bicarbonate [Moles/volume] in Arterial blood

426

2116

2.15

42.93

7.0

24.24

24.52

mmol/l

0.84

407

2023

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

539

2924

1.99

42.76

4.1

3.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

449

2292

2.09

42.09

2.9

2.2

65.48

57.98

u/l

0.08

397

1919

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

119

307

3.97

40.90

2.7

1.9

30.39

22.12

u/ml

0.35

107

277

(3027945) Reticulocytes/100 erythrocytes in Blood

613

3557

1.87

39.50

2.6

2.1

1.76

1.75

0.15

561

3099

(40768795) Lymph node Pathology biopsy report

9.89

39.20

1.2

1.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2517

21027

1.63

39.06

4.9

4.1

18.61

12.55

mm/h

34.94

2328

19259

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

434

2252

2.05

38.78

7.2

3.2

1.23

1.22

mmol/l

0.21

405

1906

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

597

3462

1.87

38.46

1.9

1.7

—

(3015736) pH of Urine

1492

11094

1.58

37.79

4.6

3.5

5.72

5.78

0.29

533

(3042936) Bacteria identified in Isolate by Culture

653

3914

1.81

37.74

2.1

—

(3047181) Lactate [Moles/volume] in Blood

238

976

2.54

37.28

5.8

6.2

1.19

1.33

mmol/l

1.87

215

869

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1452

10780

1.57

36.72

3.7

2.8

216.52

143.89

ug/l

11.44

1321

9811

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

590

3466

1.84

36.30

1.9

1.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

121

356

3.48

34.36

1.6

1.3

0.67

0.65

nmol/l

0.26

116

343

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

113

318

3.63

34.32

1.6

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1069

7483

1.60

34.20

2.3

3.32

2.95

mg/l

4.45

920

6315

(3023520) Reticulocytes [#/volume] in Blood

476

2668

1.90

33.79

2.9

2.2

66.53

67.99

e9/l

0.40

356

2050

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

120

356

3.45

33.64

1.6

1.3

0.20

0.36

nmol/l

0.82

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

373

1930

2.04

33.39

4.7

3.7

1.21

1.80

mmol/l

2.03

267

1393

(3023323) Follitropin [Units/volume] in Serum or Plasma

116

340

3.49

33.14

1.7

1.3

32.98

28.73

iu/l

0.51

292

(40761536) Microorganisms panel - Urine sediment

399

2124

1.99

32.96

5.5

3.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1003

6968

1.60

32.89

4.9

3.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

119

5.46

32.86

1.3

37.22

29.64

u/l

0.73

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

111

318

3.57

32.83

1.5

1.3

—

nmol/l

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

261

1186

2.29

32.50

2.0

1.8

1.45

1.80

ug/l

0.42

237

1022

(3009343) pH of Capillary blood

380

1998

2.01

32.49

4.8

3.8

7.41

7.42

0.94

233

(3003434) Protein [Mass/volume] in Pleural fluid

118

355

3.40

32.38

1.4

1.5

32.86

28.45

g/l

3.14

106

311

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

382

2022

1.99

32.04

4.8

3.8

5.15

kpa

0.04

361

1902

(3021589) Normoblasts [#/volume] in Blood

1551

11949

1.52

31.71

16.3

8.6

0.00

e9/l

0.64

1263

9692

(46235355) HIV 1 and 2 tests - Meaningful Use set

465

2649

1.86

31.26

2.0

1.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

297

1457

2.13

30.58

1.6

1.85

1.54

g/l

4.35

250

1249

(40768793) Breast Pathology biopsy report

102

5.66

30.50

1.3

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

108

320

3.45

30.36

1.4

1.5

1559.17

2589.12

e6/l

0.69

235

(3021879) Hepatitis B virus core Ab [Presence] in Serum

267

1261

2.20

30.26

1.4

—

(3012501) Base excess in Blood by calculation

166

636

2.69

29.82

5.0

4.6

2.50

2.61

mmol/l

0.18

112

416

(40768806) Pleura Pathology biopsy report

245

3.78

29.50

1.4

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

281

1368

2.14

29.49

5.5

4.8

1.71

1.64

0.58

263

1284

(3012441) Differential panel - Pleural fluid

265

3.65

29.26

1.3

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1397

10661

1.50

29.17

5.5

3.9

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

276

1344

2.14

28.94

5.6

4.9

0.94

0.87

2.77

259

1264

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

149

562

2.72

27.60

3.5

1.5

43.83

22.39

u/ml

1.56

140

533

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

133

474

2.87

27.41

5.0

3.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

142

525

2.77

27.33

1.3

1.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

438

2557

1.81

27.01

4.8

3.0

4.77

4.53

kpa

1.20

424

2456

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

10.82

26.89

1.1

1.2

—

(3045788) Cell count panel - Pleural fluid

238

3.68

26.82

1.4

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

287

3.41

26.64

1.3

1.5

82051.74

57607.83

e6/l

0.19

168

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

161

646

2.56

26.36

2.2

2.4

3.95

3.54

g/l

1.89

156

611

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

252

1231

2.12

26.17

4.4

3.0

4.26

4.42

pmol/l

1.24

226

1053

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

6.26

26.15

6.6

1.1

69.91

67.74

u/ml

0.02

(3009508) Creatinine [Moles/volume] in Urine

1361

10502

1.47

26.07

3.7

3.2

7.15

7.58

mmol/l

3.23

1122

8791

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3088

28020

1.64

25.85

26.8

14.0

35.36

24.97

mg/l

40.65

2871

22017

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

334

1820

1.92

25.55

2.0

1.6

—

(3021901) Oxygen saturation in Capillary blood

145

564

2.64

25.29

3.3

2.8

—

(40767503) Oxygen content in Capillary blood by calculation

154

619

2.55

25.13

3.2

2.5

16.41

16.49

0.08

328

(3028626) Oxygen [Partial pressure] in Capillary blood

168

707

2.44

24.87

3.4

3.5

8.18

8.00

kpa

0.56

163

689

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

141

547

2.64

24.73

1.3

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

206

951

2.24

24.65

2.3

1.5

1.76

2.74

ratio

0.63

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

115

402

2.92

24.57

1.3

1.4

—

(3012516) Albumin [Mass/volume] in Urine

1326

10279

1.45

24.36

3.8

3.2

557.78

254.58

mg/l

1.56

907

6708

(3004588) Protein electrophoresis panel - Serum or Plasma

380

2190

1.82

24.35

2.0

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

144

569

2.59

24.34

1.3

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

208

980

2.19

23.67

2.4

1.5

59.08

48.51

mg/l

1.49

172

798

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

186

840

2.28

23.46

1.3

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

207

977

2.19

23.45

2.4

1.5

78.10

35.35

mg/l

1.08

170

791

(3029937) Albumin [Presence] in Urine by Test strip

1025

7633

1.48

22.87

5.6

4.1

0.01

0.00

estimate

0.38

408

2257

(3020682) Albumin/Creatinine [Ratio] in Urine

1379

10865

1.43

22.79

4.4

3.8

23.82

8.45

mg/mmol

11.19

923

6960

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

100

4.95

22.73

1.9

2.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

391

2325

1.76

22.48

4.0

2.4

48.49

62.36

ml/min/173m2

18.38

248

881

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

173

773

2.30

22.38

2.0

1.7

—

(40768446) Kidney Pathology biopsy report

111

4.65

21.93

1.5

1.6

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

173

3.75

20.71

1.2

17.26

10.65

u/l

0.88

153

(3052851) Hemolysis interference index of Serum or Plasma

178

834

2.19

20.55

3.6

3.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

6.72

20.39

2.0

2.5

—

(3011412) CD3 cells [#/volume] in Blood

144

4.00

20.27

1.8

1.02

1.13

e9/l

0.46

132

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

809

5885

1.48

19.88

1.7

1.57

1.31

mg/l

1.31

661

4564

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

195

960

2.09

19.83

2.4

2.8

—

(21494814) CD8 cells/100 lymphocytes in Specimen

6.12

19.83

1.9

2.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1503

12239

1.39

19.65

4.7

4.0

79.23

84.52

ng/l

0.05

1222

9196

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

135

4.04

19.49

1.2

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

303

1742

1.81

19.46

1.6

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

142

622

2.33

19.26

2.1

2.3

216.66

197.12

1.61

137

595

(3017181) Myelocytes/100 leukocytes in Blood

350

2110

1.73

19.08

4.2

3.8

0.68

0.81

0.64

157

558

(3022313) Gas panel - Capillary blood

264

1466

1.86

18.97

4.9

3.9

—

(3020876) Protein [Mass/time] in 24 hour Urine

328

2.82

18.46

2.2

1.44

1.52

g/24h

0.09

157

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

141

629

2.29

18.34

1.3

1.5

—

(3011985) Renin [Units/volume] in Plasma

101

386

2.66

18.32

1.7

1.4

53.54

65.75

mu/l

0.29

342

(3015235) Bicarbonate [Moles/volume] in Capillary blood

169

816

2.12

18.10

3.7

3.1

23.88

24.89

mmol/l

2.37

164

798

(3007853) Bacteria identified in Skin by Aerobe culture

494

3303

1.57

17.85

1.9

1.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1261

10092

1.38

17.84

3.2

2317.24

1642.50

ng/l

3.51

1129

8719

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1388

11283

1.37

17.82

2.6

2.2

79.55

78.45

nmol/l

0.67

1250

9822

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

278

2.92

17.37

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

4.38

17.30

26.0

23.9

85.61

120.24

ug/l

3.74

(21494890) Protein electrophoresis panel - 24 hour Urine

290

2.87

17.25

1.4

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

263

2.97

17.24

1.3

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

106

428

2.52

17.21

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

153

726

2.16

17.14

2.3

1.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

118

505

2.38

16.90

1.4

1.7

2.42

4.56

iu/l

3.80

156

(3024928) Oxygen saturation in Venous blood

143

667

2.19

16.73

3.8

3.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

319

1946

1.70

16.61

4.0

3.6

0.57

0.63

0.28

133

491

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

347

2.66

16.61

1.3

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

329

2029

1.68

16.45

4.2

3.8

0.09

0.07

0.30

136

477

(3019225) pH of Specimen

438

2913

1.57

16.12

8.0

3.8

—

(40768441) Liver Pathology biopsy report

4.26

15.95

1.3

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

4.34

15.91

28.5

36.0

6.28

7.41

ug/l

2.54

(3022145) Colonoscopy Study observation

413

2718

1.59

15.89

1.4

1.3

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1961

17017

1.33

15.46

3.6

3.0

62.97

50.84

u/l

5.71

1797

15474

(3013512) EKG study

1129

9053

1.36

15.21

4.9

4.3

—

(3004809) Band form neutrophils/100 leukocytes in Blood

335

2.60

15.08

3.7

3.1

1.08

1.42

0.67

278

(3044889) 12 lead EKG panel

2315

20612

1.33

15.05

4.9

4.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

413

2.44

15.04

1.9

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

336

2.60

14.99

1.2

1.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

143

697

2.09

14.98

3.0

2.2

128.40

131.37

g/l

0.64

117

518

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

342

2.58

14.98

1.2

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

384

2.49

14.94

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

361

2.53

14.87

2.0

1.5

112.03

109.88

u/ml

0.10

(3037756) Immunofixation for Serum or Plasma

127

594

2.18

14.79

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

222

1262

1.81

14.79

5.6

4.1

24.20

24.75

mmol/l

1.82

208

1153

(3036489) Thrombin time

173

912

1.94

14.58

2.0

1.9

22.77

21.35

1.27

158

809

(3025159) Blasts/100 leukocytes in Blood

309

1941

1.65

14.36

4.4

3.9

0.11

0.07

0.19

116

398

(3011397) Hemoglobin [Presence] in Urine by Test strip

881

6866

1.37

14.03

4.7

3.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

203

2.99

13.73

1.2

1.4

—

(40761535) Cells panel - Urine sediment

396

2668

1.54

13.68

4.5

3.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

813

6297

1.37

13.36

4.7

4.1

1395.24

517.05

ng/l

0.39

705

5326

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

102

456

2.27

13.29

3.6

3.4

60.06

58.73

0.48

102

456

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

198

1125

1.80

13.23

2.0

1.7

—

(3000012) Reticulocyte production index

396

2.36

13.09

1.7

—

(3035880) pH of Pleural fluid

139

3.34

12.71

1.3

—

(3016750) Collection duration of Urine

196

2.94

12.70

1.8

1.9

494.80

485.27

min

0.34

143

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

115

3.59

12.68

2.1

1.4

—

(3021960) Folate [Moles/volume] in Serum or Plasma

935

7455

1.34

12.63

1.7

1.5

18.70

20.07

nmol/l

2.00

826

6287

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

214

1261

1.74

12.63

1.3

1.2

155.98

125.41

iu/ml

0.42

465

(3045142) Bone marrow Pathology biopsy report

192

2.95

12.55

1.2

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

271

2.61

12.49

3.7

3.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

365

2.36

12.18

1.3

1.4

230.78

301.50

pmol/l

1.83

308

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

372

2.34

12.13

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

372

2.34

12.13

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

207

1223

1.73

12.11

2.1

1.7

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2295

20703

1.29

11.97

6.4

3.6

15.21

14.99

pmol/l

3.81

2099

18492

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

208

1239

1.72

11.82

1.8

1.4

3.77

3.76

g/l

0.06

189

1083

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

208

1241

1.72

11.75

1.8

1.4

7.89

7.47

g/l

2.15

187

1085

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

208

1241

1.72

11.75

1.8

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

397

2.27

11.70

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.53

11.63

4.5

4.7

—

(40768797) Stomach Pathology biopsy report

517

3792

1.42

11.58

1.3

1.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

11.46

1.2

0.0

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

242

1515

1.64

11.40

4.0

2.6

0.63

0.65

0.58

242

1506

(3000570) Elastase.pancreatic [Mass/mass] in Stool

144

778

1.89

11.33

1.4

1.5

249.85

283.52

ug/g

1.21

475

(40765089) Chromosome analysis panel - Blood by G-banded

10.55

11.24

1.0

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

245

1548

1.62

11.13

4.0

2.6

1.19

1.24

0.32

245

1536

(3005719) IgG [Mass/volume] in Serum or Plasma

270

1749

1.59

11.06

2.6

2.2

10.54

10.83

g/l

0.43

245

1596

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

195

1166

1.71

10.95

1.8

1.4

10.86

10.33

g/l

0.67

174

1002

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

243

2.58

10.84

1.4

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

177

1034

1.75

10.80

2.0

1.5

1.38

0.41

g/l

1.85

155

876

(3051651) Icteric interference index of Serum or Plasma

144

3.08

10.73

4.5

4.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

194

1168

1.70

10.63

1.8

1.4

3.20

2.93

g/l

2.64

175

1014

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

167

2.90

10.53

1.4

1.5

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

248

2.53

10.41

3.6

3.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

259

1687

1.58

10.37

5.3

3.1

24.34

25.22

mmol/l

4.13

253

1618

(3023183) Ammonium ion [Moles/volume] in Plasma

119

623

1.94

10.33

1.7

2.6

28.20

35.34

umol/l

2.80

555

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

132

3.13

10.29

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

133

3.11

10.16

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

2569

23727

1.28

9.98

34.6

16.1

15.50

15.28

1.14

2540

23182

(3020891) Body temperature

214

1352

1.62

9.75

6.3

4.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

221

2.56

9.69

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

4.08

9.69

1.2

238.53

5.45

ug/l

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

188

1154

1.66

9.60

2.3

2.4

466.13

713.89

ug/l

0.59

181

1092

(3019550) Sodium [Moles/volume] in Serum or Plasma

3142

29863

1.36

9.56

34.8

17.1

139.00

139.77

mmol/l

51.40

3098

29011

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1168

9898

1.26

9.43

2.2

196.35

237.44

u/l

0.85

1097

9223

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

195

2.64

9.41

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.50

9.33

2.5

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1605

14115

1.24

9.32

2.7

2.4

—

(3042631) Mycobacterium sp identified in Specimen

370

2.16

9.31

2.0

3.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

378

2.14

9.22

6.5

6.7

11.89

12.21

mg/l

0.24

343

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

251

2.41

9.20

1.2

1.1

77.80

57.23

u/l

0.83

226

(3003181) Sodium [Moles/volume] in Urine

101

526

1.95

8.95

1.4

53.60

62.37

mmol/l

1.88

417

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

396

2.10

8.95

1.3

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3143

29935

1.35

8.93

35.2

17.2

4.09

4.00

mmol/l

55.81

3096

29032

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

3.93

8.86

1.2

394.56

230.14

pmol/l

0.65

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

158

2.74

8.60

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

199

2.53

8.55

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

199

2.53

8.55

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

199

2.53

8.55

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

371

2.10

8.47

1.4

1.3

266.98

277.92

u/ml

0.12

225

(40761511) CBC panel - Blood by Automated count

3052

29001

1.31

8.39

27.4

13.7

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

291

2036

1.47

8.35

2.2

11.74

14.79

nmol/l

7.18

250

1801

(3004775) Volume in Urine collected for unspecified duration

289

2.24

8.28

2.0

2.2

679.00

624.03

0.56

185

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

144

858

1.71

8.26

1.7

1.4

0.00

g/l

-0.00

136

769

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

142

843

1.71

8.26

1.7

1.4

0.00

g/l

-0.00

136

766

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

149

897

1.69

8.23

2.5

2.1

191.08

119.15

ug/min

0.92

527

(3048929) Epstein Barr virus Ab [Presence] in Serum

521

1.91

8.20

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

151

2.73

8.18

1.6

1.5

4.68

7.87

u/l

0.86

129

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2811

26467

1.26

8.09

29.9

12.9

62.29

75.36

ml/min/173m2

156.52

2568

21382

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

152

925

1.67

8.07

1.7

1.4

0.01

0.03

g/l

0.45

143

835

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

3.21

7.93

3.0

2.2

36.74

44.10

1.13

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.48

7.81

2.6

2.9

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

158

986

1.63

7.62

1.8

1.4

35.99

37.70

g/l

2.80

139

831

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

103

572

1.82

7.55

1.4

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

101

558

1.83

7.53

1.4

1.6

—

(4281824) Cell count and differential, peritoneal fluid

120

2.85

7.36

1.1

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

3.49

7.26

1.5

1.4

27.13

28.51

0.07

(3028026) IgM [Mass/volume] in Serum or Plasma

206

1389

1.51

7.12

2.2

1.4

1.78

1.13

g/l

1.39

187

1250

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

5.61

7.05

1.7

1.1

1.41

2.99

ug/l

1.14

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

105

605

1.76

6.85

1.6

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.79

6.80

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

2.97

6.80

1.3

59.31

64.72

0.33

(3051611) Lipemic interference index of Serum or Plasma

283

2.10

6.65

4.0

3.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

100

2.92

6.57

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

100

2.92

6.57

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

3.81

6.53

2.0

1.5

184.68

148.92

ng/l

0.38

(3045414) Leukocytes [Presence] in Urine

189

1278

1.50

6.47

2.2

1.9

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

6.18

6.46

1.0

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

141

2.57

6.44

1.6

1.8

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

274

2.10

6.40

1.5

1.4

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

274

2.10

6.40

1.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

166

2.43

6.35

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

119

2.70

6.33

1.3

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

119

2.70

6.33

1.3

1.2

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

540

1.76

6.23

1.6

1.1

61.24

22.67

u/l

0.88

468

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

162

2.42

6.19

2.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

104

2.80

6.15

1.4

1.5

476.20

451.29

e6/l

0.12

(3006922) Hepatitis E virus Ab [Presence] in Serum

135

2.53

5.94

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

107

647

1.67

5.92

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

107

647

1.67

5.92

1.3

—

(3017732) Neutrophils [#/volume] in Blood

248

1799

1.41

5.90

4.1

3.1

6.62

5.82

e9/l

0.14

201

1347

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

125

2.57

5.78

1.1

—

(3025941) Bacteria identified in Stool by Culture

195

1362

1.46

5.71

1.3

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

163

2.35

5.65

1.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

2.77

5.62

1.4

1.5

0.25

0.22

e9/l

0.13

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1464

13194

1.18

5.61

2.1

93.77

93.08

pmol/l

0.20

816

6876

(3047189) Immunofixation for 24 hour Urine

116

2.60

5.54

1.2

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.07

5.49

1.1

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

147

2.39

5.46

1.5

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.03

5.37

1.1

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.03

5.37

1.1

1.2

—

(3019150) Specific gravity of Urine by Refractometry

762

6501

1.22

5.30

5.9

4.1

1.02

kg/l

0.01

128

975

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

360

1.85

5.24

1.1

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

157

2.31

5.18

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

312

1.91

5.16

1.4

1.3

—

(3024471) HLA-A [Type]

2.94

5.14

1.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

320

1.89

5.11

1.5

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

315

1.89

5.02

1.5

1.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3119

30113

1.24

4.99

36.9

16.3

111.96

83.14

umol/l

83.94

3119

30103

(3017354) Segmented neutrophils/100 leukocytes in Blood

239

2.02

4.99

3.5

2.8

57.15

59.34

0.27

192

(3001893) Eosinophils/100 leukocytes in Pleural fluid

2.87

4.92

1.5

1.4

1.00

2.60

1.32

(3010838) Calcium [Moles/time] in 24 hour Urine

451

1.72

4.85

1.8

2.0

4.65

4.88

mmol/24h

0.21

381

(3016244) Insulin [Units/volume] in Serum or Plasma

101

2.59

4.80

2.7

3.0

17.33

21.02

mu/l

0.52

(3042111) Morphology [Interpretation] in Bone marrow Narrative

364

1.80

4.78

1.6

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

2.89

4.76

1.6

84.29

72.58

nmol/24h

0.16

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

307

1.87

4.74

1.5

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

624

1.60

4.72

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

308

1.86

4.70

1.5

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

151

1046

1.46

4.68

1.4

1.5

117.78

296.73

titre

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.03

4.66

1.0

1.1

0.67

0.69

umol/24h

—

(3024932) HLA-DR beta [Type]

2.85

4.65

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

127

2.37

4.64

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

127

2.37

4.64

1.1

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

121

2.41

4.63

1.4

0.20

0.22

nmol/l

0.21

(3005988) Vibrio sp identified in Specimen by Organism specific culture

310

1.85

4.61

1.5

1.3

—

(3008295) Osmolality of Serum or Plasma

268

1.92

4.58

1.3

1.4

276.05

278.18

mosm/kgh2o

0.18

204

(3032352) Blasts [#/volume] in Cerebral spinal fluid

10.02

4.52

1.3

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

342

1.80

4.49

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2702

25819

1.18

4.44

7.1

4.4

2.15

2.07

mu/l

0.62

2483

23213

(3043410) Blood group antigens tested for on Red Blood Cells

2.93

4.44

2.2

1.3

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.07

4.40

1.2

0.79

1.75

mmol/l

—

(21494755) Public health laboratory ask at order entry panel

1503

0.65

4.37

1.3

1.4

—

(40765096) Chromosome analysis panel by Banding

4.25

4.31

1.0

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

139

2.24

4.24

1.3

1.2

34.00

19.92

u/l

0.87

119

(3042733) HLA Ab [Presence] in Serum

2.63

4.22

6.8

4.9

—

(3000494) Fungus identified in Specimen by Culture

392

3190

1.26

4.22

1.6

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

395

1.71

4.18

1.4

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.91

4.16

1.8

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

154

2.15

4.11

2.1

1.8

2.04

2.85

u/field

0.22

106

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

129

2.26

4.05

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

175

2.07

4.05

1.0

1.3

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

5.01

4.00

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

2.89

3.89

1.0

1.1

—

(3002079) Sodium [Moles/time] in 24 hour Urine

119

2.28

3.87

1.1

1.2

196.74

170.49

mmol/24h

0.47

119

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

7.29

3.86

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

278

1.81

3.83

1.0

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

140

2.15

3.76

1.3

6.9

63.14

69.52

mg/l

0.19

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1073

0.63

3.63

1.8

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.75

3.58

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

255

1.81

3.58

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

376

1.66

3.54

2.4

2.1

15.17

23.57

mg/l

1.43

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3095

30062

1.19

3.53

17.4

9.3

27.84

26.13

u/l

0.53

2998

28665

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

113

2.22

3.41

1.3

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

113

2.22

3.41

1.3

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1515

14054

1.13

3.37

5.1

3.8

3.35

2.06

ug/l

2.08

1356

12623

(3000330) Specific gravity of Urine by Test strip

210

1628

1.31

3.37

5.0

3.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

360

1.65

3.31

3.5

27.5

6.95

7.53

mmol/l

0.76

299

(3025549) Creatine [Moles/time] in 24 hour Urine

4.36

3.30

2.3

1.5

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

111

780

1.44

3.29

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

510

1.54

3.29

1.4

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

102

2.26

3.28

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

779

8731

0.86

3.28

3.4

3.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

176

1.94

3.28

1.1

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

219

1.84

3.27

1.1

—

(3011648) Oxygen content in Venous blood

234

1.80

3.25

3.3

2.0

9.74

11.04

1.24

234

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

124

1700

0.72

3.24

2.1

1.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

156

2.00

3.24

2.5

1.6

113.24

2850.55

u/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.67

3.22

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

111

785

1.43

3.19

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

111

790

1.42

3.09

1.2

—

(3022621) pH of Urine by Test strip

244

1952

1.27

3.09

3.5

3.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

118

852

1.40

3.04

6.2

4.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.84

3.02

5.3

4.6

—

(3004451) EKG impression Narrative

168

1.91

2.99

1.2

1.3

—

(3023419) Bacteria identified in Sputum by Culture

498

1.52

2.98

2.3

2.6

—

(3022475) Manganese [Moles/volume] in Blood

10.01

2.98

1.6

1.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.47

2.95

1.1

—

(3045424) Erythrocytes [Presence] in Urine

461

1.53

2.90

1.6

1.4

—

(40768443) Skin Pathology biopsy report

146

1101

1.34

2.89

1.3

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

251

1.72

2.88

1.3

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

207

1639

1.28

2.87

2.4

2.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

4.45

2.79

3.4

3.3

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

4.45

2.79

1.9

4.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.58

2.78

1.1

1.96

1.89

umol/24h

—

(3017704) Immunofixation for Urine

180

1.84

2.77

1.2

—

(3016038) Potassium [Moles/volume] in Urine

210

1.77

2.74

1.1

1.2

35.71

34.37

mmol/l

0.11

179

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

674

1.42

2.73

1.5

1.8

11.95

11.85

mg/l

0.04

616

(3014051) Protein [Presence] in Urine by Test strip

106

767

1.39

2.73

2.6

2.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

145

1103

1.33

2.72

1.5

1.7

37.19

38.11

u/l

0.20

125

923

(3027923) C peptide [Moles/volume] in Serum or Plasma

167

1.86

2.71

1.2

1.3

1.44

1.20

nmol/l

0.23

124

(4034850) Laboratory test

1083

0.69

2.70

18.0

10.3

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

6.01

2.70

9.3

5.2

469.67

359.30

umol/l

—

(3008536) Aspergillus sp Ab [Presence] in Serum

3.01

2.69

3.7

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

364

3090

1.20

2.66

2.9

3.2

321.05

227.01

ng/l

1.60

342

2843

(3007566) Smooth muscle Ab [Titer] in Serum

670

1.41

2.65

1.1

1.2

80.00

117.86

titre

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

147

1.91

2.65

1.6

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

147

1.91

2.65

1.6

1.2

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.15

2.64

1.2

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2815

28948

0.88

2.63

5.4

2.52

2.61

mmol/l

5.88

2532

26443

(3020393) Adenovirus Ag [Presence] in Stool

3.61

2.57

1.0

1.9

—

(3007164) IgA [Mass/volume] in Serum or Plasma

510

4475

1.16

2.52

1.5

1.3

2.60

2.69

g/l

0.36

311

2533

(3035320) C reactive protein [Mass/volume] in Body fluid

187

1.77

2.48

2.0

2.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.82

2.46

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

121

913

1.34

2.43

1.4

1.3

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

6.26

2.37

6.2

5.6

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

2.42

2.36

1.4

2.27

1.89

umol/l

0.86

(3019309) Folate [Moles/volume] in Red Blood Cells

727

6586

1.13

2.25

1.8

1235.64

1147.13

nmol/l

1.25

564

4924

(21494434) Karyotype in Bone marrow

216

1.67

2.25

1.1

1.2

—

(3048879) Bone marrow aspiration report

2.28

2.24

1.5

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

255

1.61

2.24

2.6

2.1

3.78

1.60

u/field

0.87

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.11

2.22

1.1

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

399

3471

1.17

2.22

1.2

1.3

528.45

526.50

titre

0.00

739

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

2.69

2.20

2.1

1.4

13.68

54.21

u/l

0.54

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2751

28239

0.90

2.15

4.9

4.8

4.37

4.47

mmol/l

5.66

2499

25906

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

298

1.55

2.13

3.0

3.8

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.00

2.04

1.0

—

(3048689) Calprotectin [Mass/mass] in Stool

326

2812

1.17

2.03

2.4

2.2

251.52

163.96

ug/g

0.63

255

2214

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

458

1.43

2.03

1.3

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.08

2.01

1.3

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2729

27993

0.90

1.99

4.9

4.8

1.32

1.41

mmol/l

29.03

2463

25508

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.03

1.95

1.1

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

105

1.91

1.95

2.1

2.6

—

(3044927) Protein electrophoresis panel - Urine

387

1.45

1.94

1.3

1.2

—

(3014891) Appearance of Pleural fluid

2.57

1.94

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.73

1.93

1.1

1.2

—

(3019977) pH of Arterial blood

181

1.66

1.88

2.0

2.3

7.41

7.43

0.66

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

3.19

1.88

6.3

7.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.19

1.88

1.6

2.5

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

3.19

1.88

3.1

3.6

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.09

1.86

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

372

3273

1.15

1.81

2.6

2.5

5.18

7.64

ug/l

2.55

327

2862

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.06

1.80

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

728

1.31

1.80

1.4

1.5

0.26

0.23

g/l

1.88

688

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

531

1.36

1.76

1.1

1.2

4.26

7.24

u/ml

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

750

1.30

1.73

1.4

1.23

1.17

g/l

1.06

706

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.92

1.72

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

126

1.75

1.67

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

135

1.71

1.62

1.3

—

(3008898) HLA-B27 [Presence]

664

0.70

1.62

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

420

1.39

1.61

3.5

2.2

—

(3016018) Differential panel - Cerebral spinal fluid

248

1.50

1.54

1.3

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

340

3019

1.14

1.49

1.3

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.44

1.47

1.0

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

129

1057

1.23

1.47

1.2

—

(3017569) Oxygen content in Arterial blood

179

1.57

1.45

1.7

1.8

—

(3035285) Chloride [Moles/volume] in Venous blood

430

1.35

1.43

3.5

2.2

104.67

105.93

mmol/l

1.01

425

(3041354) Potassium [Moles/volume] in Venous blood

430

1.35

1.43

3.5

2.2

4.28

4.10

mmol/l

3.02

425

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

784

0.75

1.42

1.5

1.7

5.76

4.45

mg/l

0.37

570

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2650

27084

0.92

1.41

4.4

4.3

1.50

1.30

mmol/l

24.83

2360

24447

(3003327) Ova and parasites identified in Stool by Light microscopy

741

1.26

1.37

2.0

1.7

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.94

1.36

3.0

1.3

—

(3023410) Appearance of Cerebral spinal fluid

240

1.46

1.34

1.5

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.78

1.28

1.4

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.78

1.28

1.4

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.78

1.28

1.4

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

2.29

1.26

1.8

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

838

7873

1.08

1.26

3.2

2.7

0.86

0.72

ug/l

4.18

638

5398

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

269

1.42

1.25

1.2

1.1

—

2.55

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

120

997

1.21

1.24

1.4

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.86

1.23

1.0

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

3151

31076

1.10

1.21

43.2

20.5

38.85

40.49

14.61

2918

28496

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.63

1.21

1.4

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.16

1.21

2.5

2.6

0.25

0.35

u/field

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.31

1.18

1.3

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

736

6904

1.08

1.15

1.8

1.7

21061777.00

30877547.78

pmol/l

0.18

603

5632

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.50

1.15

1.0

—

(3006653) Thiamine [Moles/volume] in Blood

150

1.54

1.14

1.1

1.2

128.26

144.33

nmol/l

1.23

150

(3014271) Vancomycin [Susceptibility]

191

1.47

1.13

2.7

3.0

—

(3007461) Platelets [#/volume] in Blood

3151

31099

1.09

1.12

42.6

20.4

245.08

239.99

e9/l

3.72

3097

30076

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.34

1.12

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.71

1.11

1.3

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

184

1.47

1.10

1.7

—

(3024731) MCV [Entitic volume]

3151

31105

1.09

1.10

42.3

20.3

91.19

91.51

3.12

3119

30479

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.38

1.09

1.2

1.1

—

(3010813) Leukocytes [#/volume] in Blood

3151

31107

1.09

42.5

20.4

7.24

6.80

e9/l

19.74

3084

29943

(3035941) MCH [Entitic mass]

3151

31107

1.09

42.3

20.3

30.11

30.50

24.56

3119

30483

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.82

1.09

1.4

1.2

—

(3026361) Erythrocytes [#/volume] in Blood

3151

31108

1.09

1.08

42.5

20.4

4.36

4.51

e12/l

41.64

3085

29948

(3000963) Hemoglobin [Mass/volume] in Blood

3151

31113

1.09

1.06

42.7

20.5

129.62

136.82

g/l

106.56

3122

30491

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

153

1.51

1.06

2.3

2.4

—

(4062490) Immunoglobulin typing, IgG

245

1.39

1.05

1.0

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

383

0.70

1.04

1.1

1.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

779

1.21

1.03

1.7

1.6

0.42

3.99

iu/ml

0.54

183

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.27

1.03

1.0

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.27

1.03

1.4

1.1

0.02

0.99

u/ml

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.64

1.03

1.2

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2770

28156

0.93

1.03

5.8

5.0

6.19

6.10

mmol/l

2.87

2489

25338

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.06

1.02

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.06

1.02

2.6

2.5

—

(3003338) MCHC [Mass/volume]

2278

23295

0.94

1.02

38.0

18.4

329.84

332.72

g/l

36.70

2260

23081

(3026389) Candida sp identified in Specimen by Organism specific culture

325

1.33

1.00

1.8

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.71

0.98

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

223

1.39

0.98

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

740

1.21

0.96

4.9

3.1

7.19

7.76

mmol/l

1.56

717

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.85

0.96

1.2

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.69

0.95

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.89

0.94

1.1

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.22

0.93

2.0

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

108

918

1.18

0.93

1.7

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.72

0.92

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

442

0.74

0.92

1.3

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.14

0.91

1.0

1.5

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

232

0.65

0.91

1.5

1.4

150.92

213.93

pmol/l

0.75

232

(3029075) Extractable nuclear Ab panel - Serum

1.75

0.90

1.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

245

1.35

0.89

1.0

1.4

0.37

0.41

g/l

0.32

181

(3028192) IgG subclass 2 [Mass/volume] in Serum

245

1.35

0.89

1.0

1.4

2.56

3.02

g/l

0.78

180

(3027135) IgG subclass 1 [Mass/volume] in Serum

245

1.35

0.89

1.0

1.4

6.99

6.87

g/l

0.06

182

(3000034) Microalbumin [Mass/volume] in Urine

324

1.30

0.88

3.7

3.0

95.18

34.94

mg/l

1.05

249

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.61

0.87

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

649

1.21

0.86

1.1

1.2

3.14

6.04

u/ml

—

102

(3008037) Lactate [Moles/volume] in Venous blood

779

1.19

0.85

4.8

3.0

1.54

1.69

mmol/l

0.85

755

(3044290) Cell count panel - Cerebral spinal fluid

523

1.23

0.85

1.3

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.59

0.84

1.7

1.6

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

139

0.57

0.83

1.4

1.57

1.52

g/l

—

139

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

253

2777

0.90

0.83

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

249

1.33

0.81

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

249

1.33

0.81

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

355

1.27

0.81

1.2

5.79

5.61

u/ml

0.03

163

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.77

0.0

1.1

—

29.62

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

640

1.19

0.76

1.1

1.2

2.10

2.79

u/ml

—

(3005322) IgE [Units/volume] in Serum or Plasma

166

1484

1.12

0.76

1.3

1.2

232.54

252.16

u/ml

0.10

148

1368

(3001019) Free T4 and TSH panel - Serum or Plasma

735

0.83

0.75

1.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.52

0.75

2.1

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.52

0.75

2.1

2.6

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

100

1.50

0.72

1.7

1.6

8.49

9.07

ug/l

0.08

(4094501) Cardiovascular stress test using bicycle ergometer

861

0.84

0.72

1.1

—

(3021788) Differential panel - Synovial fluid

571

1.19

0.72

1.4

—

(3025577) Chromium [Mass/volume] in Blood

228

0.70

0.69

2.5

2.0

3.96

1.83

ug/l

0.47

189

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.85

0.68

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.60

0.68

1.7

1.8

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

204

0.69

0.68

1.2

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

110

1.46

0.68

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

110

1.46

0.68

1.4

2.6

107.81

93.98

0.58

103

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1172

11346

1.05

0.68

4.4

3.8

23.33

24.42

1.63

639

5514

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

117

0.60

0.67

1.6

1.8

25.19

85.17

ug/l

—

108

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

632

1.17

0.66

1.6

1.5

1.00

0.80

nmol/l

1.30

517

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

125

1111

1.13

0.65

1.5

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.57

0.65

1.3

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

304

1.25

0.65

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

438

0.80

0.64

3.6

4.3

300.32

349.57

umol/l

1.49

372

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

555

5278

1.06

0.63

1.2

1.3

1.90

1.95

u/ml

0.02

130

1366

(3000492) Spirometry study

267

2474

1.09

0.63

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

370

1.22

0.61

1.0

1.2

86.90

191.20

miu/ml

—

134

(3025130) Human papilloma virus identified in Specimen

139

0.65

0.60

2.1

1.8

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.54

0.59

1.3

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.0

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

408

3855

1.07

0.58

4.6

5.0

30.85

32.92

3.51

291

2576

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

594

1.16

0.58

1.2

3.96

mmol/l

0.01

554

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.58

0.0

1.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.51

0.58

1.4

1.2

94.38

98.18

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

263

0.76

0.56

1.1

0.93

0.81

u/ml

—

111

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.55

1.6

1.5

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.62

0.55

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.45

0.55

1.1

947.23

1670.61

miu/ml

1.98

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

366

1.20

0.55

1.2

6.11

2.78

u/ml

0.37

111

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.46

0.54

1.9

1.4

12.53

9.17

ug/l

1.05

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

240

1.25

0.53

2.1

2.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

169

0.71

0.52

1.2

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

443

1.18

0.51

1.0

1.1

1.55

459.04

iu/ml

0.66

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

161

1.31

0.51

3.0

4.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

325

0.80

0.50

1.5

1.2

38745.67

232772.57

e6/l

2.39

224

(3017315) Amylase [Enzymatic activity/volume] in Urine

144

1.32

0.50

1.1

1.2

377.89

366.61

u/l

0.02

131

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.46

0.50

1.0

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.46

0.50

1.0

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

118

1.36

0.50

1.3

1.1

0.98

1.10

u/l

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

234

1.24

0.49

1.0

1.1

—

98.90

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

813

7872

1.04

0.48

1.7

1.58

1.35

mmol/l

9.66

687

6527

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

190

1.26

0.48

2.1

1.8

—

(3038026) Centromere Ab [Units/volume] in Serum

237

1.23

0.45

1.0

1.2

—

59.76

—

(3052592) Norovirus Ag [Presence] in Stool

1.45

0.44

1.2

1.3

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

395

1.17

0.43

1.6

1.5

75.43

63.58

1.57

262

(3027456) Digoxin [Moles/volume] in Serum or Plasma

773

1.12

0.43

3.0

3.1

0.82

0.84

nmol/l

0.10

595

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.40

0.42

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.43

0.41

1.2

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.52

0.41

1.4

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.39

0.0

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

288

1.18

0.39

1.6

1.9

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.39

0.38

1.0

—

(3033799) Differential panel - Peritoneal fluid

1.34

0.38

1.4

1.8

—

(3020650) Glucose [Presence] in Urine

1.31

0.37

1.2

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

141

1311

1.08

0.37

1.4

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

290

1.17

0.36

1.2

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

310

0.84

0.36

1.0

1.1

2.16

1.57

u/ml

0.14

158

(3028707) Methadone [Presence] in Urine by Screen method

180

1.22

0.35

1.6

2.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

347

1.15

0.35

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

201

0.80

0.35

1.1

2.88

2.38

u/ml

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

190

0.79

0.35

1.8

2.1

18.71

16.67

nmol/l

0.41

173

(3050129) First trimester maternal screen panel - Serum or Plasma

0.62

0.35

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

266

0.83

0.35

1.0

1.1

7.54

3.93

u/ml

—

129

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

124

0.73

0.35

1.6

1.5

—

(3002619) Bacteria identified in Specimen by Culture

1.40

0.35

1.3

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

301

1.16

0.35

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.33

0.33

1.0

1.2

—

(4146454) Self-monitoring of blood glucose

387

1.14

0.33

2.9

2.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

397

1.14

0.33

1.6

1.5

—

(3016879) Cocaine [Presence] in Urine

350

1.14

0.32

1.6

2.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

105

1133

0.92

0.32

1.0

1.1

—

(3044941) Cell count panel - Synovial fluid

522

1.11

0.31

1.5

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

202

1.19

0.31

1.0

—

(3022689) Creatine [Moles/volume] in Urine

0.72

0.30

2.0

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

229

0.83

0.30

1.1

1.96

1.22

u/ml

—

120

(3039443) Prostate specific Ag panel - Serum or Plasma

672

0.91

0.30

1.7

1.6

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

468

1.11

0.29

1.1

1.2

52.70

42.86

u/ml

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

108

0.74

0.29

1.5

1.4

—

(3006270) Folate [Moles/volume] in Blood

279

1.15

0.28

1.1

1.2

336.53

323.47

nmol/l

0.13

222

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

140

0.79

0.28

1.1

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

375

0.88

0.27

1.5

1.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

739

1.08

0.27

1.8

1.7

—

(3009871) Measles virus Ab [Titer] in Serum

1.25

0.27

1.6

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.69

0.26

4.4

7.5

—

(40762814) Titanium [Mass/volume] in Blood

0.68

0.26

2.6

2.2

—

3.43

—

(3051101) Glucose [Moles/volume] in Cord blood

0.67

0.25

8.2

7.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

578

1.09

0.25

1.4

1.3

664.52

906.96

e6/l

0.20

484

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

578

1.09

0.25

1.3

1.2

53.85

27.67

e6/l

0.23

460

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.20

0.25

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

105

1.24

0.24

1.2

1.1

—

(3051593) INR in Capillary blood by Coagulation assay

189

1.17

0.24

11.0

11.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

307

0.88

0.23

1.4

1.9

—

(3004616) Nuclear Ab [Presence] in Serum

341

1.12

0.23

1.1

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.32

0.23

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

898

0.93

0.23

1.8

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

660

0.92

0.22

4.5

3.6

30.70

28.27

mg/l

0.18

431

(1002224) Polysomnography panel

886

0.94

0.22

1.0

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

107

1.22

0.21

1.1

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

9.16

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.21

0.0

1.4

—

1.67

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2711

27253

0.98

0.21

7.2

6.5

41.47

40.93

mmol/mol

2.07

2498

24984

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

126

1.19

0.21

1.6

1.4

—

(3042517) Benzodiazepines panel - Urine

0.00

0.21

0.0

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

211

1.14

0.20

2.3

1.8

95.63

93.54

umol/l

0.10

211

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

7.7

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.18

0.19

1.3

—

64.00

—

(3027008) Opiates [Presence] in Urine

375

1.09

0.19

1.6

2.0

—

(3035933) Granulocytes/100 leukocytes in Blood

1.13

0.18

1.5

—

(3028300) Cannabinoids [Presence] in Urine

376

1.09

0.18

1.6

1.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

363

0.91

0.18

1.4

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

217

2242

0.97

0.18

1.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

187

1805

1.04

0.18

1.3

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

184

0.87

0.17

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

184

0.87

0.17

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

184

0.87

0.17

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

129

1.16

0.17

1.2

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

148

1.15

0.16

1.2

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

388

1.08

0.16

1.3

1.7

1.08

0.93

g/l

0.20

303

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

101

1.19

0.16

1.3

1.6

79.67

152.63

umol/l

—

(40757373) Influenza virus identified in Isolate

1.14

0.16

1.4

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

409

4175

0.98

0.16

1.2

17.72

14.72

u/ml

0.25

137

1543

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

130

1.15

0.15

17.3

14.8

1617.80

1400.42

nmol/l

0.57

125

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

1.10

0.15

1.2

1.6

179.67

165.43

—

(3034426) Prothrombin time (PT)

1.08

0.14

1.0

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

372

1.08

0.14

1.6

2.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

181

0.88

0.14

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

181

0.88

0.14

1.0

1.1

11.13

3.89

u/ml

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

181

0.88

0.14

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

181

0.88

0.14

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

191

0.89

0.13

1.1

1.2

11.35

9.55

mmol/l

0.64

179

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

138

0.87

0.13

1.1

1.2

—

(3011288) Drugs identified in Urine by Screen method

239

1.09

0.12

2.5

2.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

114

1.14

0.11

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.16

0.11

22.3

7.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

819

1.04

0.10

1.6

1.5

12918.06

13670.56

e6/l

0.09

597

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

173

1.10

0.10

1.3

1.5

5.19

6.44

u/l

0.99

148

(3024263) Appearance of Synovial fluid

187

0.91

0.10

1.2

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

646

0.96

0.09

1.1

5.62

9.63

u/ml

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

1.09

0.09

4.6

2.2

46.40

46.23

umol/l

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.06

0.09

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

145

0.90

0.09

1.5

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.13

0.09

20.4

7.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

1.11

0.09

1.0

1.5

30.73

26.30

g/l

—

(3036180) Methadone [Presence] in Urine

1.03

0.08

1.2

1.6

—

(3027944) Amphetamines [Presence] in Urine

371

1.05

0.08

1.6

1.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.78

0.08

1.0

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

0.78

0.08

1.4

2.0

16.84

14.63

g/l

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

437

4418

0.99

0.08

1.3

41.27

40.27

iu/ml

0.04

137

1346

(4200892) Spirometry reversibility

214

2176

0.98

0.08

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.04

0.08

1.0

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.84

0.07

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.84

0.07

1.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.84

0.07

1.5

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.84

0.07

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.82

0.07

1.0

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

336

0.95

0.06

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

0.86

0.06

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

138

1.09

0.06

4.3

3.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

142

0.92

0.06

1.2

—

(44813793) Dust mix specific IgE antibody measurement

151

0.93

0.05

1.1

1.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

961

1.02

0.05

1.2

0.46

0.78

u/ml

—

(36660697) Celiac disease serology panel - Serum

197

1946

1.01

0.05

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

201

0.94

0.04

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

411

4137

0.99

0.04

12.6

7.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

583

0.98

0.03

1.2

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

278

2801

0.99

0.03

1.6

1.8

1.58

1.57

0.08

233

2384

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

183

1.04

0.01

1.8

1.2

0.47

1.92

u/ml

1.27

105

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

176

0.97

0.00

1.1

0.20

9.57

nmol/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

584

1.01

0.00

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

644

1.01

0.00

1.8

1.9

221.25

203.52

pmol/l

0.62

607

(3025018) Bordetella pertussis Ab [Titer] in Serum

121

0.99

0.00

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

814

0.99

0.00

1.6

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

106

1.04

0.00

2.9

5.6

60.33

69.36

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

476

1.01

0.00

1.1

1.3

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

294

0.99

0.00

1.3

1.4

16.58

27.39

1.51

198

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

175

1749

1.00

0.00

2.3

2.4

23.24

23.19

au/ml

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

273

0.99

0.00

1.1

13.60

2.83

u/ml

—

(3005033) Fetal Nuchal fold Thickness US

0.94

-0.00

1.5

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

3.88

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3044007) Cell count panel - Peritoneal fluid

0.86

-0.00

1.6

2.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

0.92

-0.00

1.5

2.2

2.01

1.23

ug/l

—

(3007463) Buprenorphine [Presence] in Urine

0.00

-0.00

0.0

2.6

—

(3028433) Virus identified in Specimen by Culture

0.96

-0.00

1.3

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.91

-0.00

1.5

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

6.4

—

0.21

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1352.00

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

218.30

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

-0.00

0.0

1.4

—

(3001556) Androgen free Index in Serum or Plasma

0.00

-0.00

0.0

1.2

—

(3015183) Erythrocyte sedimentation rate

1.00

-0.00

1.3

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

0.86

-0.00

1.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

40.20

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.94

-0.00

1.5

1.4

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

178.00

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

8.64

—

(3034614) HLA Ag [Interpretation]

0.00

-0.00

0.0

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.91

-0.00

1.4

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.87

-0.00

1.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_KIDNEY_NOTRENALPELVIS – Malignant neoplasm of kidney, except renal pelvis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of kidney, except renal pelvis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of kidney, except renal pelvis (C3_KIDNEY_NOTRENALPELVIS)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints